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ABSTRACT  
   
Lung Cancer Alliance, a nonprofit organization, released the "No One Deserves to 
Die" advertising campaign in June 2012. The campaign visuals presented a clean, simple 
message to the public: the stigma associated with lung cancer drives marginalization of 
lung cancer patients. Lung Cancer Alliance (LCA) asserts that negative public attitude 
toward lung cancer stems from unacknowledged moral judgments that generate 'stigma.' 
The campaign materials are meant to expose and challenge these common public 
category-making processes that occur when subconsciously evaluating lung cancer 
patients. These processes involve comparison, perception of difference, and exclusion. 
The campaign implies that society sees suffering of lung cancer patients as indicative of 
moral failure, thus, not warranting assistance from society, which leads to 
marginalization of the diseased. Attributing to society a morally laden view of the 
disease, the campaign extends this view to its logical end and makes it explicit: lung 
cancer patients no longer deserve to live because they themselves caused the disease (by 
smoking). This judgment and resulting marginalization is, according to LCA, evident in 
the ways lung cancer patients are marginalized relative to other diseases via minimal 
research funding, high- mortality rates and low awareness of the disease. Therefore, 
society commits an injustice against those with lung cancer. This research analyzes the 
relationship between disease, identity-making, and responsibilities within society as 
represented by this stigma framework. LCA asserts that society understands lung cancer 
in terms of stigma, and advocates that society's understanding of lung cancer should be 
shifted from a stigma framework toward a medical framework. Analysis of identity-
making and responsibility encoded in both frameworks contributes to evaluation of the 
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significance of reframing this disease. One aim of this thesis is to explore the relationship 
between these frameworks in medical sociology. The results show a complex interaction 
that suggest trading one frame for another will not destigmatize the lung cancer patient. 
Those interactions cause tangible harms, such as high mortality rates, and there are 
important implications for other communities that experience a stigmatized disease. 
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CHAPTER 1 
INTRODUCTION 
 Lung Cancer Alliance’s “No One Deserves to Die” campaign made the audience 
uncomfortable. It made the audience think about its attitude toward lung cancer patients. 
And now, Lung Cancer Alliance has moved on to another type of campaign. However, 
the attention grabbing “No One Deserves to Die” campaign of June 2012 deserves an in 
depth examination. The campaign aimed to dissociate stigma from lung cancer, but is 
exemplary of larger epistemological issues of understanding disease.  
 This thesis offers a case study of a recent example of framing the perception and 
experience of disease in terms of stigma. The case study examines Lung Cancer Alliance 
(LCA), a nonprofit organization, and its “No One Deserves to Die” campaign.1  This 
campaign asserts that lung cancer is stigmatized in American culture, and calls on society 
to reform its attitude about this disease. Neither the campaign, educational materials, nor 
the staff at Lung Cancer Alliance demonstrate a unified theory of stigma. Furthermore, 
the organization does not present concrete, primary evidence for stigma in society. This is 
significant to the analysis of a campaign for a nonprofit organization whose mission is to 
“end injustice” to lung cancer patients caused by stigma.2 The organization draws an 
implicit parallel with other cancers, highlighting the apparent disparity of research 
funding and attention between lung cancer and breast cancer. Effectively, the parallel 
looks to a disease (breast cancer) that has experienced what Lung Cancer Alliance 
considers success. By comparison, lung cancer is still blamed on the patient, whereas 
                                                
1 The images included in the campaign can be found in Appendices A and B. 
2 Lung Cancer Alliance. 2012a. “About Us.” 
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breast cancer is no longer understood in those moral terms and is now understood 
epidemiologically. Susan Sontag, a breast cancer patient herself, stated “[the language 
about cancer] must change, decisively, when the disease is finally understood and the rate 
of cure becomes much higher.”3 By this, Sontag means the moral implications that 
accompany cancer will diminish as the disease becomes less of a public health issue. If 
this were the definition of destigmatization, breast cancer could be considered 
destigmatized as a result of the emergence of multiple drugs were found to effectively 
treat breast cancer. This comparison is highly relevant to lung cancer, currently the 
second highest cause of death in the United States. Lung Cancer Alliance is looking for 
destigmatization of lung cancer via treatments and awareness. However implicit, this is 
the picture of destigmatization for which LCA is striving. 
 Further, this analysis is extremely relevant to the Lung Cancer Alliance case as 
the organization not only pushes for medical treatment but also social understanding and 
tolerance of those affected by the disease. LCA asserts that the public carries a certain set 
of ideas, assumptions, and practices that structure or frame its understanding of disease, 
in this case, lung cancer specifically. The organization characterizes social understanding 
of lung cancer by attaching “stigma” to the common set of assumptions about lung 
cancer, which they judge to be the incorrect method of understanding. This “incorrect 
method” for understanding disease is a barrier preventing lung cancer from achieving any 
appreciable progress in either raising federal funding or decreasing mortality rate. LCA 
reveals this assessment of the stigma framework, or structure for understanding, in a 
                                                
3 Sontag, Susan. 1989. AIDS and Its Metaphors. New York: Doubleday, 86 
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minimalistic way in the campaign and other LCA materials. However, its presence is 
powerful. The resulting stigma narrative of lung cancer colors the connection between 
lung cancer and stigma in negative language. The “No One Deserves to Die” television 
advertisement tells the audience “Lung cancer doesn’t discriminate; neither should you.” 
This account of the story tries to offer a reason for shifting the frame through which 
relationships between the disease, the individual’s identity and responsibility are made. 
However, it glosses over how and where these relationships are made. LCA’s call for 
reordering public understanding of disease, by changing its set of common assumptions 
and practices, both reveals LCA’s perspective of how society currently understands lung 
cancer, and implies that LCA has a picture of what lung cancer would mean if it were 
destigmatized. When LCA observes a change in their proxy measures for stigma, more 
funding and lower mortality rate for example, it would signify to the organization that a 
shift away from the stigma frame has occurred to some extent.  
 This case suggests that the stigma frame has come to circulate in general discourse. 
As such, it has taken on a distinct meaning that is so clear that Lung Cancer Alliance 
need not explain what stigma means. The organization does not provide a definition of 
stigma and has a proxy measure for stigma experienced in society. Stigma as a concept is 
not easily quantified. However, the campaign has traction without direct evidence of 
stigma. The minimalist nature of the campaign reflects the common sense arguments the 
organization makes about stigma and its function in framing public understanding of lung 
cancer. A negative perspective of the disease in question has become embedded in the 
definition of stigma, shown by a limited genealogy of the concept. LCA takes this 
attitude as a given. LCA assumes the audience understands stigma as exclusionary and 
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negative. Little theorizing regarding the definition or support for their claims occurs in 
either the campaign itself or the educational materials. It is significant that LCA provides 
evidence that is actually a secondary measurement, a proxy, of stigma because it tells a 
simple story. In utilizing these proxy measures, and by not utilizing a complicated direct 
measurement of stigma, LCA does not have to convince the audience that what is being 
presented is stigma. LCA is able to use statistics to paint a simple story that the harms 
captured in lung cancer’s low survival rate and funding are caused by stigma. The 
simplicity of the story predisposes the audience to accept the narrative LCA provides 
rather than uncover its underlying complexity. LCA’s simplification of the reasoning can 
be mapped as such: lung cancer stigma= unjust attitude = exclusion. The narrative of this 
understanding ignores how these connections are made.  
 I will demonstrate that this simple map represents a significant amount of work 
that LCA does not address. I am interested in interrogating the complex pieces of the 
narrative that are flattened, or oversimplified, by explaining this social problem in terms 
of stigma. In trying to understand what function stigma plays, it is useful to ask: how is 
stigma operationalized in the Lung Cancer Alliance advertising campaign? By 
operationalized, I mean how has LCA put the background theoretical work to use in order 
to achieve the goal of confronting public attitudes about lung cancer in the campaign? Put 
differently, what work is the concept of stigma doing for LCA in its campaign? What 
features of the concept are packed into the term of stigma that allow it to be used in this 
way?  I will demonstrate that using the stigma framework flattens out this relationship. 
How does their use of the stigma narrative in this way make this possible? 
 From my analysis of the case, informed by Charles Rosenberg’s work explaining 
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disease frames, it becomes clear that relationships of disease, identity-making and 
responsibility are encoded with normative claims and disease frames are morally laden. 
Lung Cancer Alliance (LCA)  says stigmatization is a moral framing of disease. Other 
scholars have identified disease frames as an interesting area for discussion, as framing 
disease is an important place to observe social relationships. Charles Rosenberg states 
that disease is an important locus through which social relationships are negotiated by 
asserting that “every aspect of an individual’s social identity is constructed—and thus 
also is disease,”4 and “once crystalized… disease serves as a social actor and mediator.”5 
By this, Rosenberg is proposing an idea that interacts nicely with Ian Hacking’s proposal 
of “dynamic nominalism” in order to say that disease functions as a tool to categorize 
people in new ways and, conversely, as an existing category in which to place types of 
people as they emerge into public consciousness.6 For the purposes of this thesis, the 
concept of a disease frame will be considered as a given due to an extensive amount of 
research and discourse that has already negotiated the definition of a disease frame. If we 
set aside any disagreements about what a disease frame is, and, in this thesis, consider a 
disease frame to be a set of assumptions informing understanding and a method of 
practices that constitute the representation of some disease.7 Rosenberg’s discussion of 
disease frame indicates a frame is a system of understanding and responding to a disease 
                                                
4 Rosenberg, Charles E. 1989. “Disease in History: Frames and Framers.” The Milbank 
Quarterly 67 (Supplement 1), 2 
5 Ibid., 10 
6 Hacking, Ian. 2002. “Making Up People.” Historical Ontology. London: Harvard 
University Press, 105 
7 Rosenberg, Charles E. 1989. “Disease in History: Frames and Framers.” The Milbank 
Quarterly 67 (Supplement 1), 7 
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in such a way that incorporates place, time-period, and social considerations, in addition 
to the biological nature of the disease. If we use Rosenberg’s formulation of ‘disease 
frame,’ it is clear that it is important background for the case study and questions at hand. 
This specific case and disease frame, is interesting because it is applied to a disease, lung 
cancer, that society continues to blame on the individual. As such, society inserts 
normative claims about the identity of the individual with lung cancer. This moral frame, 
or method of understanding, is not appropriate, according to LCA, because it allows for 
injustice toward lung cancer patients. In constructing the problem of injustice in this 
particular way, Lung Cancer Alliance collapses a complex problem of social attitudes, 
and the unmediated effects of those attitudes, into a simple statement that says society-at-
large has the wrong attitude about stigma and society is at fault for the resulting injustice. 
The simplicity of the statement masks the true meaning of its implicit components. By 
packaging the problem as stigma, LCA is able to move forward with simple statements 
without theorizing the problem. The goal here is not to speculate whether they should or 
should not undertake this project in this way, but to think about how they tackled the 
topic and why their method is significant.  
 LCA did not have to explain what they meant by stigma. LCA’s meaning of stigma 
is not exactly reflected by Erving Goffman’s traditional definition, “the situation of the 
individual who is disqualified from full social acceptance.”8 Goffman’s concept of stigma 
has been influential in defining the relationship between individuals and disease. His 
theoretical contributions have been widely discussed, critiqued and disseminated. Though 
                                                
8 Goffman, Erving. 1963. Stigma: Notes on the Management of Spoiled Identity. New 
York: Simon & Schuster, Preface.  
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the concept has changed over the past 50 years, Goffman’s formulation is still widely 
cited. Yet the audience understood what was meant by “stigma” in the campaign by mere 
common sense. No reference to Goffman or any other theoretical definition was 
necessary. Furthermore, the organization is not asking whether stigma exists, rather it is 
telling society that it has these attitudes, but we just have not examined them. LCA’s 
stigma framework actually indicates that a normative assessment has been made of the 
individual. He is not only disqualified, but also unworthy of social acceptance. In addition 
to implying the meaning of stigma, on the assumption that society has a common sense 
understanding of what stigma means, the campaign implicitly pushes for a response to 
these injustices that places the lung cancer patient in the medical frame. These areas of 
collapse (where the organization does not explain the concept or work that the concept 
signifies) allow LCA to tailor theoretical frameworks into a small, practically applicable, 
package and match them to tangible, but proxy, measures of injustice. LCA glosses over 
these important topics of social theory. I am interested in breaking LCA’s narrative apart 
to understand the complexities of stigma, medicalization, and the social interaction that 
contributes to both frames. 
 Identity-making and responsibility are a central focus of the 2012 Lung Cancer 
Alliance campaign. The campaign visually represents attitudes which LCA states are 
wrong. The visuals implicitly point to certain ways identity is constructed. These methods 
for identity construction are not explained. It is assumed the audience understands what 
they are and the common sense reasoning Lung Cancer Alliance is utilizing to state this 
method of constructing identity is stigmatizing. Given that Lung Cancer Alliance’s 
stigma narrative flattens out the relationship between disease, identity making and 
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responsibility, how is this relationship made? Put another way, by virtue of invoking the 
term ‘stigma,’ what can go unsaid? The stigma framework encodes normative judgment 
in the relationship between identity-making and responsibility. A stigmatized 
understanding of lung cancer is rooted in a public logic that inserts moral assessment into 
judgment of difference, as LCA implies. This kind of identity-making and attribution of 
responsibility is not specific to lung cancer. However, it is significant that this type of 
explanation exists for lung cancer. Such an explanation legitimates LCA’s call for 
medicalization of lung cancer since society strives for moral neutrality, especially in 
relation to disease. This is reflected in society’s emphasis on objective data and, in the 
medical frame, epidemiological explanations for disease. Public awareness singles out 
cigarettes as a major source of cancer-causing agents, or carcinogens. The social 
knowledge states that smoking = lung cancer = death. Carcinogens ingested mainly by 
smoking is a clear, discrete cause of lung cancer. Therefore, lung cancer is already 
medicalized. Yet, lung cancer is not intitially presented by LCA to the audience through 
statistics that empirically show the toll lung cancer takes on the population, including 
those who do not smoke. Instead, the disease is presented in terms of stigma, which is 
rooted in moral kind-making. LCA tells the audience that they view the disease with 
unjust preconceptions generated from negative identity-making. This could be understood 
as: stigma= unjust attitude= exclusion. LCA states that this is the wrong way to 
understand the disease and that there is a corollary relationship between the disease and 
social interactions that is the correct way to understand the disease. Given the aspiration 
toward moral neutrality, LCA implies that the medical frame is the correct frame within 
which to understand the disease by emphasizing a reform of the proxy measures of 
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stigma such as minimal federal funding, high mortality rate and low awareness. It is not a 
question of whether their proposed interventions are correct or incorrect. What is 
significant is that they have proposed this problem (a “stigmatized” understanding of 
disease) that they say represents injustice. Furthermore, the organization roots the 
injustice in failure of public responsibility toward the diseased. In order to decrease these 
secondary outcomes of stigmatized understanding of disease, LCA proposes the problem 
be medicalized.  
 The stigma and medical frames of disease surprisingly share several common 
methods for constructing the relationship between disease, identity and responsibility. 
Theorists of social interaction and medical sociology have shown that disease and health 
have long been a locus of moral identity. I have borrowed from this body of theory on 
stigma and medicalization, using these concepts as tools to provide an analysis of social 
relationships brought to the forefront by the “No One Deserves to Die” campaign. The 
moral character of the stigma framework bears on understanding of disease when 
comparisons of people and their behavior with unstated norms yield differences that can 
be blamed on the patient. Lung cancer is different from other cancers because the 
assumed difference is smoking, which is an irresponsible social behavior. As such, lung 
cancer patients are excluded, and their identity is largely assumed based on past 
demonstration of irresponsibility toward health. How, then, is the perspective of the 
problem of injustice toward lung cancer patients shifted by medicalizing the relationship 
between disease, identity-making and responsibility? The same types of social interaction 
attributed to the ‘unacceptable’ stigma frame also occur in the ‘neutral’ medical frame. In 
the medical frame, the patient becomes actively responsible for managing his disease. 
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Difference is assessed on this basis when the patient fails to carry out his patient role as 
expected. In order to maintain a positive moral identity in this frame, the patient is 
responsible for prioritizing his health in the manner in which the physician deems 
appropriate. The patient is only excluded, then, if he does not manage his disease 
properly. Therefore, identity is dependent on an active responsibility toward health. The 
moral vestiges that persist in the medical framework problematizes the cleanliness of 
medicalizing lung cancer completely, as implied by LCA.  
 This thesis uses the case study as an analytical tool to dissect the moral aspects of 
the disease frame. I begin in chapter one by providing a description of the case, Lung 
Cancer Alliance’s “No One Deserves to Die” campaign. In undertaking this study, I 
conducted a thorough examination of the campaign itself, and I reviewed the 
organization’s published educational and informational materials. These documents 
included fact sheets, press releases, the legislative bills and the Lung Cancer Alliance 
blog. I also conducted a phone interview with the Communications Manager for Lung 
Cancer Alliance (LCA).9 In chapter two, I go on to analyze important aspects of the case. 
I began with the case study and case analysis because the case is arresting yet the topics it 
emphasizes are not theorized. By organizing my discussion in this way, the thesis follows 
the progression of the story of Lung Cancer Alliance and the “No One Deserves to Die” 
campaign. Starting with the case provides a foundation describing society’s common 
sense understanding of the disease and of stigma. Proceeding from this basis, this thesis 
will then discuss what is hidden or overly simplified in the common sense understanding 
in order to bring a richer understanding of the features that made this case interesting and 
                                                
9 The interview questions discussed above can be found in Appendix C. 
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an important area for research. Therefore, the reader is lead into a theoretical discussion 
of the two disease frames LCA focuses on, the stigma (chapter 3) and medical 
frameworks (chapter 4), after the case discussion to be able to understand the theories 
with common background knowledge. These later chapters engage primarily with the 
theoretical literatures on stigma and medicalization theory. The literature I rely on 
includes a variety of books, peer-reviewed articles, and popular news stories. These were 
assessed and selected from various sources including online databases and citations in 
related literature based on relevance and contribution to the discussion at hand. LCA 
frames the problem of injustice toward lung cancer patients as a problem of stigma. The 
organization offers a solution in the form of medicalizing our understanding of lung 
cancer. Framing the disease in these terms influences identity- making and claims of 
responsibility. My aim is to use this case as an entrypoint into theoretical discussions that 
elucidate how disease, identity-making and responsibility interact in these frameworks. 
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CHAPTER 2 
THE "NO ONE DESERVES TO DIE" CAMPAIGN  
I. Introduction 
 The June 2012“No One Deserves to Die” advertising campaign released by the 
Lung Cancer Alliance tells the audience that we hold preconceived notions about lung 
cancer patients, whether we have thought about it or not. As a result, lung cancer patients 
are excluded from funding and awareness which benefit other patients of other types of 
cancer. LCA measures this in terms of secondary markers, which it considers injustices 
experienced by lung cancer patients: low public awareness; minimal federal funding; low 
priority in Congress and government agencies like the National Institutes of Health and 
the Centers for Disease Control and Prevention; and low quality of care in screening 
clinics. In order to correct for these largely quantitative measures of injustice, LCA is 
pushing for medical solutions. 
 Lung Cancer Alliance (LCA) has constructed its own narrative about the situation 
of lung cancer patients. The nonprofit organization employs stigma as a method of 
understanding lung cancer. Not only does LCA present this to the audience as the wrong 
frame, but LCA assumes that the audience knows what this frame means. The common 
sense basis for this argument makes this case especially interesting as an analytical tool to 
understand the way society understands disease. The areas of rich theoretical knowledge 
that are flattened, or where the complexity is ignored, in order to make a simple argument 
are significant. It is in these spaces that the resulting argument ignores the theoretical 
work that informs how and where relationships between disease and society are made. By 
asking how stigma is operationalized in the Lung Cancer Alliance advertising campaign, 
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I will unpack the relationships that are flattened due to framing the disease in terms of 
stigma.  The goal here is to address the call for better understanding of “the influence of 
culture on the definitions of disease and of disease in the creation of culture, and the role 
of the state in defining and responding to disease.”10  
 In this chapter I will explain the campaign and the nonprofit organization’s unique 
position that provides a background for its unique narrative. I will examine the actor’s 
(LCA) efforts to fulfill its mission: “ending injustice and saving lives through an alliance 
of advocacy, education and support.” I am representing the story here as it is provided by 
LCA. The claims regarding ‘injustices’ to lung cancer patients, so named by LCA, are the 
organizations claims. I will neither support nor refute those claims here, as that is not the 
goal of this thesis. I provide evidence from a third party that supports the legitimacy of 
the organization as a non-profit which aims to aid patients, but this thesis should not be 
read as an endorsement the organization outright. This is not the proper forum to discuss 
any skepticism about the organization itself or its nomenclature of low survival rates or 
low awareness as ‘injustices.’ Rather, the goal of this thesis is to simply understand and 
analyze the stigma narrative LCA provides. The description of the case in this chapter 
will lead into a discussion in the next chapter about the actor/analyst role LCA plays in 
asserting that lung cancer is framed in terms of stigma, and discussion of their 
interventions leading to the call for a reformation of society’s understanding of lung 
cancer.  
 
 
                                                
10 Rosenberg, Charles E. 1989. “Disease in History: Frames and Framers,” 14.  
  14 
II. “No One Deserves To Die” 
 The inspiration for this project came in June 2012 when the nonprofit 
organization Lung Cancer Alliance released the “No One Deserves To Die” campaign. 
The campaign was released as bus shelter, print, television, social media and online 
advertisements. Besides my previous interest in the social life of cancer, the campaign 
caught my attention, and indeed it was designed to do precisely this. The campaign is 
comprised of a collection of six arresting images, each depicting a different group of 
people defined by a single characteristic or feature.11 The pictured types of people are not 
individuals with lung cancer, but they are types of people who experience the same 
discrimination as individuals with lung cancer patients experience. For explanatory 
effect, Lung Cancer Alliance applies the same reasoning about the identity of an 
individual with lung cancer to other types of people to show that the exclusionary 
conclusions society reaches about lung cancer patients are non sequitur. For example, one 
image depicts a young man in clothing and accessories most commonly belonging to the 
popular ‘hipster’ style. The term hipster and the subculture it refers to carry varying 
connotations and could otherwise be characterized as ‘progressive’ or representative of 
independent thinking; regardless of the connotation, the goal of the visual is simply to 
present the outer appearance of this individual. The statement that he and others like him 
deserve to die is striking. I am perplexed; why do hipsters deserve to die? Based on the 
given information in the visual, the poster seems to assert that is that this particular 
individual deserves to die because of his hipster identity-- his outward appearance and 
stylistic affiliation with the hipster subculture. The hipster subculture carries certain 
                                                
11 See Appendix A 
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connotations, and the group is commonly judged due to the superiority its members 
typically assert of themselves over others in mainstream culture. His outer appearance is 
a marker of the meanings behind this group. The campaign shows how this particular 
hipster is compared with others and considered different. His difference is being 
understood and ascribed a certain moral character. That moral character is deemed of 
lesser value, and is excluded. However, the conclusion that all hipsters are bad people 
and deserve to die is such a blunt, discriminatory assertion that counters our culture’s 
celebration of diversity and identity. Lung Cancer Alliance tells us this can be understood 
as stigma.      
 By design, the campaign ran without explanation for a full week; the public was 
only confronted with the attention grabbing line telling us that certain groups of people 
“deserve to die.”12 No further explanation was provided. The campaign received a strong 
reaction; the visuals became known as “the posters so provocative that people tore them 
down.”13 After one week had passed, the Lung Cancer Alliance (LCA) released more 
information regarding the intention behind the campaign.14 The viewer was directed to 
NoOneDeservesToDie.org where he would learn about lung cancer, the injustices faced 
by lung cancer patients (for which the organization blamed stigma), and the need for 
improved attitudes regarding the disease. LCA released a television advertisement at this 
point as well which helped explain the connection between the original judgment 
(someone “deserves to die”) and the message that society needs a new attitude about this 
                                                
12 See Appendix A. 
13 “Campaigns: Hipsters Deserve to Die.” Luerzer’s International Archive. Accessed 
September 5. http://www.luerzersarchive.com/content/show/id/53666. 
14 See Appendix B. 
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disease. The television ad depicts a woman at home, joyfully making clothing for her cat. 
After the scene unfolds, the text displayed on the screen asserts, “Cat lovers deserve to 
die… if they have lung cancer.” The voice- over then states, “Lung cancer does not 
discriminate; neither should you” and displays the website “NoOneDeservesToDie.org” 
and the organization’s name and logo.15  
 The goal of the campaign was twofold; first, to stimulate conversation, and 
second, to “reverse long held perceptions that people have about [lung cancer].”16 To do 
so, the text of the campaign was not only intended to be repellant, it was also intended to 
show that the audience harbors those feelings about lung cancer patients. The idea is that 
conversation would arise when the audience realizes previously its previously 
unappreciated moral judgments about lung cancer patients. Laughlin Constable, the 
advertising agency responsible for creating the “No One Deserves to Die Campaign,” 
clearly describes the theme of the campaign: 
 “Lung cancer is a disease, not a punishment. The No One Deserves To Die  
 campaign used in-life teasers to seed the conversation in dozens of cities across  
 the country, as the first step in ending the stigma associated with this, the number  
 one cancer killer.”17 
 
 A large portion of the message of the campaign hinges on the visual 
representation of these 6 types of individuals in relation to the blanket judgment made in 
the overlay text about this type of person in the background. This interplay is meant to 
                                                
15 Lung Cancer Alliance. 2012a. “Cat Lovers Deserve to Die”. YouTube Web site. 
Accessed October 15.  http://youtu.be/ST2MTUcl8EM. 
16 Laurie Fenton- Ambrose. 2012c. “‘No One Deserves to Die’ Campaign.” YouTube 
Web site. Accessed October 5. http://www.youtube.com/watch?v=SFcfRDnx6E4. 
17 Emphases added. Laughlin Constable. 2012. “The Lung Cancer Alliance: No One 
Deserves To Die.” http://www.laughlin.com/clients/lung-cancer-alliance/campaigns/no-
one-deserves-to-die/work/no-one-deserves-to-die-website-5. 
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mimic the thought process one undergoes when making a first impression and judgment 
about an individual. Lung Cancer Alliance uses this appeal to connect with the audience. 
In the process, LCA states public perception, formed by commonly held assumptions and 
practices, is in need of reform. In this way, visual presentation of a common thought 
process is meant to transition the viewer into reflection about his own attitudes. The 
overall intention was to provide society with a specific example of attitudes that it 
ostensibly harbors—attitudes that should be reformed. The logic behind the campaign is 
that by doing this work, generating internal awareness, individuals will be induced to 
discuss their personal observations with their peers; thereby, produce a conversation, and 
a national discourse about lung cancer. In so doing, awareness of the disease and 
awareness of the injustice that LCA calls stigma is raised. As wider discourse leads to 
reversal of common perceptions of the disease, the second goal of the campaign, 
exclusion felt by lung cancer patients would be diminished. The tangible, but secondary, 
injustices to this group can be reformed. Those injustices are measured by the LCA in 
various ways, including amount of federal funding, legislative action and level of care in 
the clinic. These will be discussed below. First, a description of the nonprofit 
organization helps legitimate their standing and explain why Lung Cancer Alliance is a 
group worth consideration. 
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III. Lung Cancer Alliance 
 Lung Cancer Alliance brands itself as the leading lung cancer activist group. They 
claim to be the “only nonprofit organization dedicated solely to support and advocacy.”18 
It was recognized as one of the “Top Nonprofits” by Philanthropedia in 201119 and is 
ranked three out of four stars by Charity Navigator20, both of which are independent 
nonprofit groups that analyze other nonprofit groups’ financial and activist activities. It is 
significant that other activist groups also target lung cancer specifically, two of which 
also occupy top spots on Philanthropedia.com and Charitynavigator.org. All three fall 
under the the category for national organizations benefitting cancer; Lung Cancer 
Alliance is ranked #10, National Lung Cancer Partnership is ranked #12, and Lungevity 
Foundation is ranked #15 on the “Top Nonprofit” list in 2011.21 Philanthropedia ranks 
nonprofit organizations based on expert analysis which incorporates expert perception of 
nonprofit’s impact.22 Experts, including policy makers, researchers, academics, 
professionals, etc. are invited to recommend nonprofits in their area and answer a 
questionnaire to explain their recommendation and provide support for the organization’s 
impacts. Conflicts of interest are eliminated by excluding recommendations for 
nonprofits which the expert is professionally affiliated with.  
                                                
18 Lung Cancer Alliance. 2012a. “About Us.” Accessed July 8. 
http://www.lungcanceralliance.org/about-lca/. 
19 Philanthropedia.org. 2011. “Ranked Nonprofits: National Cancer 2011.” 
http://www.myphilanthropedia.org/top-nonprofits/national/cancer/2011. 
20 Charitynavigator.org. 2013. “Health: Diseases, Disorders, and Disciplines: Lung 
Cancer Alliance.” Accessed October 2. 
http://www.charitynavigator.org/index.cfm?bay=search.summary&orgid=10469#. 
UmC4PySoVU9. 
21 See note 15. 
22 Philanthropedia.com. 2013. “How We Rank.” Accessed October 2. 
http://www.myphilanthropedia.org/how_we_rank. 
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 Another site, Charitynavigator.org, assesses nonprofit organizations based on two 
major categories: 1.) accountability and transparency and 2.) financial responsibility. 
Accountability and transparency is assessed based on 17 points, which include the 
presence and accessibility of the organization’s policies such as the whistleblower and 
donor privacy policies. The organization’s financial responsibility is assessed based on 
data obtained from the organization’s published Form 990 disclosing the organizations’ 
financial breakdown providing information such as expenses, gifts and contributions, 
revenue growth, administrative expenses, and CEO salary. These are graphed together 
producing a number out of 70 combining both measures and an overall score. Lung 
Cancer Alliance received a 58.14/70 and three out of four stars as of fiscal year- end in 
December 2012.23 National Lung Cancer Partnership received a 56.89/70 and three out of 
four stars as of fiscal year-end in December 2011.24 Lungevity Foundation received a 
59.58/70 and three out of four stars as of fiscal year-end in June 2012.25  
 By these measures the top nonprofits are nearly identical. All three are legitimate 
nonprofit organizations with a wide scope of national support and funding. Each 
organization is aiming to make a large scale impact. However, the focus of each group 
                                                
23 Charitynavigator.org. 2013. “Health: Diseases, Disorders, and Disciplines: Lung 
Cancer Alliance.” Accessed October 2. 
http://www.charitynavigator.org/index.cfm?bay=search.summary&orgid=10469#. 
UmC4PySoVU9. 
24 Charitynavigator.org. “Health: Diseases, Disorders, and Disciplines: National Lung  
Cancer Partnership.” Retrieved October 2.  
http://www.charitynavigator.org/index.cfm?bay=search.summary&orgid=11072 
#.UmM 8BCSoVU8. 
25 Charitynavigator.org. “Health: Diseases, Disorders, and Disciplines: LUNGevity 
Foundation.” Accessed October 2. 
http://www.charitynavigator.org/index.cfm?bay=search.summary&orgid=10606#.UmM 
7nCSoVU9. 
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differs greatly. This can be summarized most clearly through their stated missions and 
visions. Each articulates the goal to reduce lung cancer mortality, or number of deaths, in 
either the mission or vision statement. National Lung Cancer Partnership emphasizes 
“research, awareness and advocacy” to achieve this goal by 2022.26 Lungevity 
Foundation’s stated vision is “a world where no one dies of cancer,” and aim to achieve 
this vision by emphasizing “quality of life…survivorship…, early detection, and 
support.”27 Lung Cancer Alliance’s mission is “ending injustice and saving lives through 
an alliance of advocacy, education and support;” their vision is to reduce lung cancer 
mortality to 50 percent of it’s current rate by 2020.28 Lung Cancer Alliance’s goal of 
“ending injustice” places the organization in a unique position as the only one of its class 
directly aiming to reduce injustice, identified in terms of stigma, surrounding the disease. 
LCA differs from the other two organizations in that it frames the core problem of lung 
cancer as being the product of social marginality, and explains the marginality of the 
disease in terms of stigma. Thus LCA’s mission to mitigate marginality by enacting 
destigmatization. Destigmatization, to LCA, means reframing public perception of lung 
cancer in terms of medicine and biomedical research. This shift would transform the 
problem from a social and moral problem into a purely medical problem. It is the 
centrality of the notion of stigma, and the corollary of distigmatization as medicalization 
that makes this group an interesting focus for this case study.  
                                                
26 National Lung Cancer Partnership. “About Us: Mission and Vision.” 
NationalLungCancerPartnership.org. Accessed October 1. 
http://www.nationallungcancerpartnership.org/about-us/mission-vision. 
27 LUNGevity Foundation. “About Us.” Lungevity.org. Accessed October 1.  
http://events.lungevity.org/site/PageServer?pagename=v2_AboutUs 
28 Lung Cancer Alliance. 2012a. “About Us.” Accessed July 8. 
http://www.lungcanceralliance.org/about-lca/. 
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 Lung Cancer Alliance is a non-profit organization based in Washington D.C. and 
is the largest lung cancer advocacy group in the world. Lung Cancer Alliance (LCA) was 
founded in 1995 under the name Alliance for Lung Cancer Advocacy Support and 
Education (ALCASE). In 2005, LCA established headquarters in Washington D.C., and  
in 2012, established the Lung Cancer Alliance National Advocacy Advisory Council in 
addition to the medical and professional advisory board and honorary board it has 
assembled. The CEO, Laurie Fenton Ambrose and Chairman T. Joseph Lopez sit on the 
National Advisory Council, in one of the organization’s most recent efforts to address 
Lung Cancer Alliance’s national goals. LCA’s reported mission is “ending injustice and 
saving lives through an alliance of advocacy, education and support;” their vision is to 
reduce lung cancer mortality, or number of deaths, to 50 percent of it’s current rate of 
roughly 160,000 per year by 2020.29 LCA aims to achieve these goals by addressing 
under-represented problems at all levels of society. These levels are represented by 
LCA’s three programs. First, they support individuals with lung cancer by offering 
individual help through the Community Outreach and Support Services Program; second, 
they advocate specifically for lung cancer research and related policy action in the 
legislature via the Health Policy Program; and, third, through National Awareness 
Programs. These include Give a Scan, Team Lung Love, and the National Shine A Light 
on Lung Cancer Vigil, specifically intended to “empower[sic] families to help eliminate 
stigma.”30 In addition, LCA has released several national awareness campaign aimed at a 
                                                
29 Lung Cancer Alliance. 2012a. “About Us.” 
30 See Note 25. 
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more general audience via the “No One Deserves to Die” campaign and the subsequent 
“Moments” campaign.  
   
IV. Measuring Injustice 
  Lung Cancer Alliance represents the diminished status of lung cancer in the eyes 
of society in several ways, as stated previously. During a phone interview with the 
Communications Manager at LCA, we discussed the difficulty with measuring stigma 
and successes in confronting stigma. I asked her how Lung Cancer Alliance determined 
stigma was a problem, and how the organization measured this problem. She responded 
by saying the organization had not measured stigma directly. Tellingly, she instead 
offered examples of indirect indicators. She said that LCA seeks to impact change by 
increasing federal funding for lung cancer- specific research; by passing legislation that 
will fund plans to improve 5- year- survival rates of cancers with less than 50 percent 
survival rate; and by improving standard of care for the at- risk and patient population. 
Though we did not directly discuss the parallel with breast cancer apparent in other 
materials, her discussion of the low 5-year-survival rate indicated that the current 
statistic, placing survival rate just below 16%, could be improved by following the breast 
cancer model. Improvement of the 5-year-survival rate for breast cancer is correlated 
with increased federal research funding and preventive screening according to LCA’s 
published educational materials.31 The implication is that if the public perception and 
attention is supportive, medical interventions provided by more funding, and better care 
will follow, as it did with breast cancer. In addition, the website and LCA news has a 
                                                
31 See Note 25. 
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heavy focus on legislative action. Given these discrete manifestations of injustice, it 
becomes easier for LCA to mark the “No One Deserves to Die” campaign as a success. In 
providing tangible harms that can be corrected, LCA is saying that society will know 
lung cancer has been destigmatized when it is given the medical and research attention it 
deserves. The more interesting parallel story describes society shifting its perception 
about individuals with lung cancer in such a way that the disease is separated from the 
individuals’ moral identity.  
 Lung cancer is the second leading cause for death in the United States with a 5-
year- survival rate of only 15.9 percent. 32  The National Center for Health Statistics 
reported that in 2009 158,158 people died of lung cancer, second only to heart disease 
which accounted for the death of 599,413 people in the same year.33 The National Center 
for Health Statistics reported that in 2009 158,158 people died of lung cancer, second 
only to heart disease which accounted for the death of 599,413 people in the same year.34 
28,000 of those who died had never smoked; LCA repeatedly reports that 80% of new 
lung cancer cases occur in former smokers or those who have never smoked. LCA feels 
that the continuing high impact of lung cancer is both an injustice to patients and a result 
of unmitigated injustices in multiple sectors. The organization attributes low survival rate 
and high mortality to minimal federal funding, restricted discourse about the disease due 
to stigma and inadequate options for screening and quality care.  
 In the “2012 Lung Cancer Facts” Sheet, the LCA reports that lung cancer research 
receives federal funding from the Department of Defense, the National Institutes of 
                                                
32 See Note 25. 
33 See Note 25. 
34 See Note 25. 
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Health and the Centers of Disease Control. However, the total commitment of research 
dollars is only $231.2 million. Furthermore, lung cancer research received fewer dollars 
per death in 2012 ($1,442) than it did in 2005 ($1,871). On the Fact Sheet, LCA asks, 
“Why is the survival rate for lung cancer still so low?” They answer this question right 
below: “because so little federal funding is committed to lung cancer research.” Though 
fluctuations in funding for lung cancer are small in comparison to the final per death 
expenditure, LCA implies that the fluctuations are representative of the low amount of 
national attention the disease receives. The question that follows, then, is: “why is federal 
funding still so low?” LCA is implying on the Fact Sheet and explicitly states elsewhere 
that the problem of injustice for lung cancer patients is because we understand the disease 
to be stigmatized. The organization supports the claim that lung cancer is treated as a 
second rate disease and is underfunded as a result of stigma by comparing statistics 
regarding other cancers with high mortality rates. Of the four leading causes of cancer 
deaths (lung, colon, breast, and prostate cancers), lung cancer receives the least funding 
across the board. On the fact sheet, LCA have published statistics showing federal 
funding for breast cancer was about $1 billion dollars in in 2012. Despite the fact that 
breast cancer is the 11th leading cause of death and has a 5- year- survival rate of 89.0 
percent. In 2005, breast cancer received $25,635 per death; in 2012 it received $26, 398 
per death. The most poignant comparison on the sheet is a graph depicting today’s lung 
cancer 5- year- survival rate (15.9 percent) with that from 1974-1976. The disparate 
progress made in treatment is most apparent in the increase of the 5- year- survival rate 
for breast cancer from 75 percent in 1974-1976 to 89.0 percent in 2002-2008. This 
increase represents the sharpest contrast with lung cancer, for which the 5- year- survival 
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rate has increased to 15.9 percent in 2002-2008 from only 13 percent in 1974-1976. This 
specific graph aims to represent the gains made from advanced research over roughly the 
past 30 years. The implication is that federal funding directly affects the improvements in 
mortality and 5-year- survival rates. In contrast to lung cancer, breast cancer research 
receives more federal dollars per death today ($26, 398) than it did in 2005 ($25, 635).35 
Overall, lung cancer research only receives 22 percent of the yearly research funding 
breast cancer receives ($1,043,000,000). The LCA’s argument is that lung cancer is 
underrepresented in terms of funding compared to the attention due to the disease based 
on the high mortality rate and low 5-year survival rate. The purpose of the fact sheet is to 
support this argument by presenting statistical data in order to create an understanding of 
the climate surrounding lung cancer and comparing that data with that of other common 
cancers. By showing that those cancers with the most funding have made the most 
progress in 5-year survival rate, LCA has illustrated their argument for the need for 
increased funding. The organization supports this conclusion with the statistics that show 
the gains made in terms of mortality rate due to high levels of research funding. LCA’s 
influence in legislative action and in improving health care practices can be discussed in 
terms of residual impacts of the “No One Deserves to Die” campaign. These conclusions 
are the Lung Cancer Alliance’s conclusions; I am transcribing them into words here to 
help explain their argument. Again, this is not an endorsement of their measurement or 
use of the term ‘injustice;’ this section simply serves to retell the story LCA told in the 
“No One Deserves to Die” campaign. 
                                                
35 Lung Cancer Alliance. 2012e. “2012 Lung Cancer Facts”. Lungcanceralliance.org. 
Accessed January 15. 
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 In the next section I will provide a brief discussion of the public action that 
occurred after the “No One Deserves to Die” campaign which LCA provides as evidence 
of the impact of the campaign. This discussion is provided to contextualize the campaign. 
Though the project here is not to assess the efficacy of the campaign, it is useful to 
understand the secondary markers of success LCA is using to self-assess their successes. 
This discussion will provide a broader view of the case as it is situated in society. From 
this background, we can move on toward understanding the campaign and LCA’s vision 
for how disease ought to be framed.  
 
V. Impacts 
 In our interview, Ms. Geier, Communications Manager for Lung Cancer Alliance, 
stated the first week of the campaign was successful in achieving the first goal of the 
campaign: to stimulate conversation.36 She stated this was exhibited when the campaign 
became the 2nd most popular story on Yahoo.com that week.37 Furthermore, the 
noonedeservestodie.org website received 150,000 visitors looking for information during 
the first week; Geier interprets this increased traffic as an increased opportunity for 
education, which she identified as a key feature of this approach. She explained that the 
campaign was released in 31 key markets which were chosen based on population 
density, the intent being to reach as many individuals as possible. Though Geier stated 97 
percent of conversation about the campaign was positive, the Yahoo News story 
                                                
36 Gabriele Geier. “Personal Communication” November 8, 2013. 
37 Stableford, Dylan. 2012. “‘Deserve to Die’ Posters Pop Up in Some U.S. Cities.” 
Yahoo! News, June 26. http://news.com/blogs/lookout/deserve-die-posters-ad-campaign-
lung-cancer-201119572.html. 
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references mixed responses during the first week of the campaign. From LCA’s 
perspective, people were talking about the campaign and their message. 
 Following the “No One Deserves To Die” campaign, the LCA has seen other 
impacts that could reflect changing perceptions of the disease. In the eyes of the 
advertising community, the campaign was highly creative, effective and impactful. The 
campaign received the Bronze Effie award and Silver OBIE for Public Service award for 
the campaign in 2013.38 The Effie award is a national and international award given by 
Effie Worldwide, a nonprofit organization; it marks excellence, with special attention to 
effectiveness, in marketing.39 The OBIE award is given by the Outdoor Advertising 
Association of America, and awarded by peers in advertising, for creative excellence.40  
 A larger impact of the campaign was felt in the policy arena by the passage of a 
key piece of legislation: the Lung Cancer Mortality Reduction Act of 2011. Senate Bill 
S752, The Lung Cancer Reduction Mortaltity Act, additionally states, “(8) Lung cancer is 
the most stigmatized of all cancers and the only cancer blamed on patients, whether they 
smoked or not.”41 President Barack Obama signed the Recalictrant Cancer Act, a 
combination of the Lung Cancer Mortality Reduction Act and another bill aimed at 
achieving similar goals for pancreatic cancer, into law in January 2013. The Lung Cancer 
Mortality Reduction Senate bill was originally sponsored by Dianne Feinstein (D-CA), 
                                                
38 Lung Cancer Alliance. 2013a. “LCA Campaign Wins Major Awards.” Lung Cancer 
Alliance News, May 23. Lungcanceralliance.org. Retrieved August 1. 
http://www.lungcanceralliance.org/news/lung-cancer-alliance-news/2013/lca-campaign-
wins-major-awards.html.  
39 Effie Worldwide. “About Us.” Effie.org. Accessed October 2. 
http://www.effie.org/worldwide/about 
40 Outdoor Advertising Association of America. “OBIE Awards.” Oaaa.org. Accessed 
September 12. http://www.oaaa.org/CreativeCenter/OBIEAwards/OBIEAwards.aspx 
41 112th Congress of the United States of America. 2011. S. 752.   
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Sam Brownback (R-KA), Hillary Clinton (D-NY) and Chuck Hagel (R-NE). On its third 
introduction in the 112th Congress, Senate Bill S752 was again sponsored by Feinstein, 
with the addition of Johnny Isakson (R-GA) and John Kerry (D-MA).42 On their website, 
LCA announce that their goals for the legislation, to make lung cancer a priority and 
garner bipartisan and bicameral support, were met with great success. Provisions for 
House Bill H.R. 1394 and Senate Bill S. 752 found their way into law during 112th 
Congress as an amendment to the National Defense Authorization Act for Fiscal Year 
2013, H.R. 4310 Sec. 1083 “Scientific Framework of Recalcitrant Cancers.” 43  Based on 
the facts as presented, the Senate made lung cancer a “national public health priority” and 
endorsed creation of a Health and Human Services directed mortality reduction program. 
The program directly addresses LCA’s goal to reduce lung cancer mortality rates by 50 
percent by year 2020. To achieve this, the Act authorizes funding for research and 
outreach. The National Institutes of Health, Food and Drug Administration, Centers for 
Disease Control and Prevention and others are specified in the Act, each with unique 
requirements for creating their programs. These requirements include funding research 
regarding: the interrelation of diseases; screening and interventions for lung cancer; 
environmental factors contributing to incidence of lung cancer; and prevention and 
outreach efforts. These categories are made specific depending on the agency. The Act 
also makes provisions for establishing the Lung Cancer Screening Demonstration Project, 
aimed at improving screening and care for those at risk. This project has 180 days to 
                                                
42 Lung Cancer Alliance. 2013c. “Lung Cancer Mortality Reduction Act.” Accessed 
August 15. http://www.lungcanceralliance.org/get-involved/lung-cancer-
advocacy/federal-policy/victories/lung-cancer-mortality-reduction-act/. 
43 112th Congress of the United States of America. 2013. H.R. 4310, 329 
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report the budget and will be conducted over the next five years. This section also 
codifies efforts made by the LCA for official screening center certification. Finally, the 
Act establishes the Lung Cancer Advisory Board, which will include members from 
Health and Human Services, the Secretary of Defense, the Secretary of Veterans Affairs, 
the Director of the Occupational Safety and Health Administration, and the director of the 
National Institute of Standards and Technology, in addition to medical and scientific 
experts, advocates and the pharmaceutical industry representatives. The Act is directed 
specifically at the secondary measures of injustice cited by LCA. As passed, it refers to 
“recalcitrant cancers,” defined as “a cancer for which the 5-year relative survival rate is 
below 50%,” thereby including several types of cancer, including lung and pancreatic 
cancers.44 In this way, LCA was successful in obtaining a “response [from Congress] to 
reduce lung cancer mortality in a timely manner.”45 
 Another impact of the campaign was closer to the ground level in the form of the 
United States Preventive Services Task Force (USPSTF) official recommendation of low- 
dose computed tomography (CT) screening. Approved for people 50 years of age and 
older, the screening was approved as a measure to catch and intervene on lung cancer 
earlier in its progression. Recently, the National Lung Screening Trial (NLST) study 
confirmed the efficacy of the screening test by showing a 20 percent reduction in deaths 
due to lung cancer and cost efficiency of the screening for the patient and the nation.46 
                                                
44 112th Congress of the United States of America. 2013. H.R. 4310, 332. 
45 112th Congress of the United States of America. 2011.   
46 Lung Cancer Alliance. 2013d. “New Research Further Supports Cost- Effectiveness of 
Lung Cancer Screenings Among High- Risk Populations.” Lung Cancer Alliance News, 
August 8. Lungcanceralliance.org. Accessed August 15. 
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The Lung Cancer Alliance has published the National Framework For Excellence in 
Lung Cancer Screening and Continuum of Care to establish a uniform standard of 
practice for health care professionals providing care to lung cancer patients. The 
Framework as published at this time does not specify low-dose CT screening; however, it 
will likely be revised when the USPSTF recommendation is finalized at the end of this 
year.47 Ms. Geier also mentioned the LCA’s continuing effort to urge private insurance 
companies and the Centers for Medicare and Medicaid Services recognize the screening 
recommendation and ensure low-dose CT screening. The LCA’s goal here is to reduce 
obstacles to access by ensuring insurance coverage. With such improvements to 
screening and screening centers, wider access to screening and appropriate, 
compassionate treatment is another result- in- progress of the campaign that LCA 
provides as evidence of success of their campaign.  
 According to LCA, progress is being made to improve these secondary measures 
of exclusion and injustice. This progress is what LCA envisions the process of 
destigmatization to look like. From the organization’s perspective, it has made strides in 
altering public perception of lung cancer. Now that more attention has been given to lung 
cancer, LCA has released the next step toward tackling exclusion and injustice in the 
form of a new campaign, called “Moments.”48 This campaign does not directly tackle 
stigma as the “No One Deserves to Die” campaign did. Rather, “Moments” emphasizes 
risk awareness. The basic approach for this campaign is similar to “No One Deserves to 
                                                                                                                                            
http://www.lungcanceralliance.org/news/lung-cancer-alliance-news/2013/milliman-
study-2013.html 
47 Gabriele Geier. “Personal Communication” November 8, 2013.  
48 Gabriele Geier. “Personal Communication” November 8, 2013. 
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Die:” to reach as many viewers as possible and get people talking. LCA hopes this new 
campaign will go beyond stigma, and encourage those at risk take action by getting 
screened for lung cancer. In addition, LCA hopes to encourage friends and family 
members of an at- risk individual to open a dialogue about lung cancer and screening. 
This new campaign serves as a transition toward medicalizing public perception of the 
disease. “No One Deserves to Die” confronted previously unacknowledged public 
perception, called stigma. Now that hidden norms have been brought to the forefront, 
LCA is now able to encourage people to think about how the disease touches their own 
lives. Furthermore, they encourage society to act on it as the medical problem that it is, 
rather than the moral problem we previously thought it was. Lung Cancer Alliance’s 
overall argument emerges from this description as medicalize public perception to 
destigmatize public perception of lung cancer.  
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CHAPTER 3 
DISSOCIATING THE DISEASE FROM THE DISEASED: CASE ANALYSIS  
“At the heart of their objection is the belief that no society can be regarded as socially 
just if it permits the stigmatization of certain of its minority groups.” 
- Robert Page, Stigma49 
 
I. Introduction 
 Lung Cancer Alliance’s mission is “ending injustice and saving lives through an 
alliance of advocacy, education and support.”50 The most recent effort to fulfill this 
mission, the “No One Deserves to Die” advertising campaign, was simple, although its 
message was anything but simple. The campaign was able to communicate complex ideas 
through just a few words and pictures. The fact that Lung Cancer Alliance could release a 
campaign that called the injustice experienced by lung cancer patients “stigma” and 
expected society to understand what it means without definition is significant in two 
ways. First, Lung Cancer Alliance is not merely proposing the existence of stigma. LCA 
is telling the public on no uncertain terms that stigma (negative stigma) is attached to 
lung cancer, and that it is causing negative outcomes for the lung cancer patient. Second, 
LCA is treating federal funding and clinical care statistics as a proxy for measuring 
stigma. These particular proxies are tied to public perception and public institutions that 
reflect stigma in their response to disease. More federal research funding, better patient 
care and more awareness help shape LCA’s picture of what lung cancer would look like 
                                                
49 Page, Robert. 1984. Stigma: Concepts in Social Policy. London: Routelage, 132 
50 Lung Cancer Alliance. 2012a. “About Us.”  
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if it were destigmatized. LCA’s focus on these secondary measures indicates that it has a 
vision for the right construction of public attitudes about disease. Furthermore, these 
proxies indicate the group is emphasizing that the moral implications on the lung cancer 
patient’s identity be removed. The lung cancer patient should be thought of as a patient, 
not a deviant. In Lung Cancer Alliance’s construct, progress means moving away from 
understanding this disease in terms of stigma toward understanding it in medical terms. In 
the medicalized experience of lung cancer, without stigma, LCA envisions these patients 
would enjoy inclusion, awareness and care equal that of other cancers. In addition to 
asserting that stigma exists, LCA is making an implicit assessment about responsibility. 
To counter the notion that an individual patient is responsible for  causing the disease, the 
campaign message asserts that larger society is responsible for assigning the lung cancer 
patient the status as ‘different’ from other cancer patients. LCA’s shift of responsibility 
onto society echoes Susan Sontag’s assessment of the modern discourse of the “disease 
metaphor” which “assume[s] a punitive notion: of the disease not as a punishment but as 
a sign of evil, something to be punished.”51 Thus, society is responsible for constructing 
an identity for the individual with lung cancer that stigmatizes him, casting the lung 
cancer patient’s identity in a negative light. The primary goal of the “No One Deserves to 
Die” campaign is to make viewers become aware of their own latent attitude about lung 
cancer and lung cancer patients. Through this medium, the audience is not asked whether 
they have a negative attitude; they are told that they do in fact hold a negative attitude 
toward the disease and the patient, but it is simply an attitude they have not interrogated. 
Through the “No One Deserves to Die” advertising campaign, stigma is functioning as a 
                                                
51 Sontag, Susan. 1978. Illness as Metaphor. New York: Doubleday, 81 
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way for Lung Cancer Alliance to frame society’s understanding of the disease. Within 
this framework, or set of assumptions and practices, they are able to explain the problems 
lung cancer faces in a narrative of exclusion and injustice, emphasizing society’s 
responsibility for these consequences. Using stigma as a way to tell this story also asserts 
a corollary vision of the right relationship between disease, identity and responsibilities 
of a society. The “No One Deserves to Die” campaign points to larger society as the party 
responsible for holding negative attitudes about lung cancer patients. The implication of 
the campaign is that it is society’s burden to change these negative attitudes. LCA 
indicates that the problem lies in society, as it is not the lung cancer patient’s 
responsibility to change society’s attitudes. The fact that the campaign has had impacts in 
the legislature (passing the Recalcitrant Cancer Act) and clinic (approval of low-dose CT 
screening) demonstrates that the stigma frame was effective at constructing a narrative 
that tells the audience that stigma causes exclusion and injustice. It is more difficult for 
society to refute LCA’s claims since it offers proxies for stigma that can be measured. 
Based on statistics alone, LCA’s argument that the situation warrants change seems 
reasonable. The audience received the message loud and clear from this ostensibly 
minimalist campaign. “No One Deserves to Die” touched a cultural nerve. Given these 
observations about the campaign, how is stigma operationalized in the Lung Cancer 
Alliance advertising campaign?  
 
II. A Brief Review of the History 
 Lung cancer is a disease that deserves special interest because its historical 
context makes it a different kind of cancer. I will provide a brief overview of the history 
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of smoking to provide a contextual background for the case. Then, in the following 
sections of this chapter I will offer my analysis of the case as described in the previous 
chapter. I will then deepen this analysis by providing theoretical discussions of the two 
main frameworks discussed by LCA in chapters 4 and 5. 
 Allen Brandt offers an in-depth study of the history of smoking in America in The 
Cigarette Century: The rise, fall, and deadly persistence of the product that defined 
America. His book offers discussion of the nuances of what it meant to smoke in 
America. The historical account provide a strong basis for the set of common 
assumptions society holds today about smoking and about lung cancer. Beginning from 
the cigarette as a product of labor he traced its transformation into a product exemplifying 
mass consumerism. Brandt discussed the act of smoking as a frame for the identity of 
those who could be included as consumers. He also discussed the cigarette as an object 
around which a large amount of knowledge- making was centered, becoming a locus of 
individual responsibility, especially in relation to health in both medical and legal frames. 
Much of Brandt’s expertly crafted history of this topic is beyond the scope of this project 
but provides an important background understanding of the social context that forms the 
basis for today’s understanding of the meanings of lung cancer. 
 In his expert testimony in United States v. Philip Morris (2003), Brandt explained 
that clinical, experimental and population- based knowledge contributed to the 
understanding of health effects, especially lung cancer causality, in the 1940s and 
1950s.52 He explained that the exchanges between these sectors made consensus 
                                                
52 Brandt, Allen. 2007. The Cigarette Century: The rise, fall, and deadly persistence of 
the product that defined America. New York: Basic Books, 499-500 
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regarding the link between smoking and lung cancer an elusive goal. In his book, Brandt 
depicts his testimony as a drop in the bucket of reports contradicting each other about 
knowledge of lung cancer causality and the link between smoking and adverse health 
effects during that period of time. Despite the rampant contradictory testimonies in this 
case, Judge Gladys Kessler ultimately ruled in 2006 that Philip Morris, and the tobacco 
industry as a whole, had violated the Racketeering Influenced and Corrupt Organizations 
Act of 1970 (RICO)  
 “by suppress[ing] research, … destroy[ing] documents, … manipulate[ing] the 
 use of nicotine so as to increase and perpetuate addiction,…and… abus[ing] the 
 legal system in order to achieve their [the tobacco companies’] goal—to make 
 money with little if any regard for individual illness or suffering, soaring health 
 care costs, or the integrity of the legal system.”53  
 
The finding was precedential; however, Brandt and Kessler both bemoan the fact that this 
ruling could not produce a lasting effect, beyond altering marketing practices, as Kessler 
was unable to assign punitive action.54  
 Today, the link between smoking and lung cancer is no longer contested in the 
public understanding of the disease. As early as the 1970s, anti-smoking campaigns 
began emphasizing health risks and discouraging smoking.55 Multiple lawsuits, especially 
the early class action suit Engle v. R.J. Reynolds (1999), attempted to place responsibility 
for health problems with tobacco companies due to false advertising, rather than with the 
individual.56 The medical community has recast smoking as a nicotine addiction treatable 
                                                
53 Quoted by Brandt, Brandt. 2007. The Cigarette Century, 503; cited from United States 
v. Philip Morris, et al. U.S. Dist. LEXIS 57757 (D.C. Cir. 2006):1500-1501.  
54 Brandt. 2007. The Cigarette Century, 503-504.  
55 Ibid., 286 
56 Wiener. Jon. 2010. “Big Tobacco and the Historians.” TheNation.com, June 25. 
Accessed August 30. http://www.thenation.com/article/big-tobacco-and-historians.  
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with pills and patches. The transformation of smoking from the cultural norm, and a 
common feature of a consumer society, to a nicotine addiction, and thus a treatable 
disease, is recent. Anti-smoking activism has been successful in re-casting the smoker’s 
identity; the modern smoker is no longer a consumer of a national product, but a deviant 
who, flying in the face of medical knowledge, chooses to accept the risk of developing 
serious health effects as a result of his smoking behavior. This serves to contextualize the 
basis for the stigma framework for understanding lung cancer. Society views the lung 
cancer patient as a smoker. The lung cancer patient is irresponsible for smoking and is 
risking his health, via society’s reasoning. Yet, the majority of the patient demographic is 
made up of individuals who have quit smoking (about 60% of patients) or were never 
smokers (about 18% of patients).57  
 
III. Social Reasoning  
 As a cancer, lung cancer is expected to be a “disease of the individual,” according 
to Susan Sontag.58 However, lung cancer, and its social meaning, is situated in the 
specific context of smoking. Susan Sontag states, “metaphorically, cancer is not so much 
a disease of time as a disease or pathology of space. Its principle metaphors refer to 
topography… and its most dreaded consequence, short of death, is mutilation or 
amputation of part of the body.”59 As a result, lung cancer is actually a disease of a 
perceived group of smokers. Significantly, this is a group that actively participated in the 
(previously very common) cultural behavior of smoking, which directly affects the lungs. 
                                                
57 Lung Cancer Alliance. 2012e. “2012 Lung Cancer Facts.” 
58 Sontag, Susan. 1978. Illness as Metaphor, 59 
59 Ibid., 14-15.  
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The individuals of the group are now subject to the consequence of lung cancer due to 
participation in the smoking group. Lung cancer patients as a group retain the 
‘irresponsible’ label attached to the smoking group. As such, they have become a group 
identified as a group unworthy of care, as they are personally responsible for their 
disease. It is in this way, LCA argues, that lung cancer patients are stigmatized. It is 
equally significant that this is not a perceived group of people who breathe polluted air, 
or are subject to some other common feature of society such as exposure to asbestos that 
has negative effects on the lungs. LCA does not directly address or fight against smoking, 
pollution, or exposure to asbestos. It simply advocates for tolerance for patients who were 
exposed to these carcinogens. 
 Society has adopted the simplified understanding that smoking leads to lung 
cancer. Lung cancer is the disease most strongly correlated with smoking despite the fact 
that it is well documented that smoking is strongly correlated, if not a major causal factor, 
with several other diseases as well, including heart disease.60 However, those connections 
are not emphasized as often as the connection between lung cancer and smoking. Heart 
disease has a very different disease profile and the link between smoking and heart 
disease is complicated by diet and exercise. Thus, the linkage cannot be reduced to 
‘smoking equals heart disease’ and ‘heart disease equals death.’ Not only would there 
have been too much information to impart, but the scattered effects would have reduced 
the focused attention to the body that lung cancer provides. The message that smoking 
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has negative effects on one’s health would have become less focused. Connecting lung 
cancer with smoking, however, provided a very focused message. Because of this, the 
linkage between smoking and lung cancer was able to be extremely simplified. The 
equation reads: 
  smoking = lung cancer = death. 
It may be the case that this statement was constructed to be simple and easy to remember 
in order to give it traction in the public consciousness. The obvious intention of such an 
equation is to ultimately discourage smoking by connecting it with negative 
consequences (the ultimate, negative consequence being death). A visual representation 
as above shows that lung cancer is a transition state so to speak. As such, lung cancer was 
deployed as a framework, or a set of common assumptions, for understanding the 
relationship between behavior and health. This type of reasoning also maintains the moral 
aspects of the disease in tact. The simplicity of the equation, and supposed simple 
narrative of causation very likely contributed to its longevity in the public memory. This 
narrative of causation served as the hub for a large-scale public health campaign, placing 
more weight in this disease framework.  
 The downside of the simplicity of the message is that it flattens out diversity and 
falsely ascribes simplicity to lung cancer. The true identity of the lung cancer patient is 
not reflected by the idea that smoking equals lung cancer, thus lung cancer equals 
‘smoker.’ Lung cancer, as the Lung Cancer Alliance states, can be traced back to 
environmental factors since 17.9 percent of lung cancer patients have never smoked.61 
This portion of the group is especially invisible as they are grouped in with ‘previous 
                                                
61 Lung Cancer Alliance. 2012e. “2012 Lung Cancer Facts.” 
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smokers’ and denied rights as if they too were previous smokers. All the while, the cause 
of their disease goes unaddressed. However, these individuals suffer from the same 
biological disease and experience the same ‘injustices’ (labeled as such by LCA) as other 
lung cancer patients in the form of minimal federal funding for research and 
advancement. 
 The diminished increase in 5- year- survival rate, and low general awareness of 
lung cancer are equally influenced by factors beyond federal funding. The 
marginalization of the disease as represented by minimal funding and successes is due to 
low national awareness, activism, and political action. In contrast, other cancers, such as 
breast cancer and colon cancer, which have much greater national awareness and support, 
higher 5-year- survival rates (lower mortality rates) and enjoy a larger allocation of 
federal funding, according to LCA. The injustices of decreased funding and 5-year-
survival rate that has only had marginal improvements are rooted in lung cancer’s 
association with smoking. In a video discussing the “No One deserves To Die” campaign, 
Michael Jeary, President of Laughlin Constable, the advertising agency responsible for 
the campaign, explains the issue. He states that the problem with “associating tobacco, 
smoking, with lung cancer is that it allows people to dismiss the disease.”62 The 
conflation of smoking and lung cancer marginalizes the lung cancer patient group. This is 
problematic in that it ignores a large proportion of individuals who die of lung cancer and 
had never smoked. The “We Are Lung Cancer Alliance” video discussing the campaign 
explains that 80 percent of those diagnosed with lung cancer either never smoked or have 
                                                
62 Jeary, Michael. 2012c. “‘No One Deserves to Die’ Campaign.” YouTube Web site. 
Accessed October 5. http://www.youtube.com/watch?v=SFcfRDnx6E4. 
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quit smoking.63 LCA emphasizes the holistic 80 percent statistic in the video, whereas in 
the Fact Sheet, the statistic is broken into its parts, stating that in fact 60 percent of those 
with lung cancer were former smokers and 17.9 percent had never smoked.64 The activist 
group does not aim to emphasize smoking behaviors, except to illustrate that lung cancer 
occurs in non- smokers and therefore, understanding the disease within the stigma 
framework is especially harmful to the 17.9 percent with claim to environmental causes. 
In fact, smoking behavior is secondary to the main argument, as understanding lung 
cancer within the stigma framework is harmful to all lung cancer patients who are in need 
of support, regardless of the presence/absence of personal causative behavior.65 The “No 
One Deserves to Die” campaign was intended to confront this unexamined attitude on the 
national scale. 
  
IV. Looking at the Areas of Collapse 
 Lung Cancer Alliance’s “No One Deserves to Die” campaign is deceptively 
simple. The materials presented to the public are clean and represent a unified message. 
The message can be summarized as follows: ‘despite the appearance of a moral 
difference, lung cancer patients are like any other cancer patient; those individuals 
deserve care and support rather than exclusion. Exclusion from access to treatment and 
support stems from society’s attitude about lung cancer, so society needs an attitude 
adjustment.’  
                                                
63 Lung Cancer Alliance. 2012d. “We Are Lung Cancer Alliance.” YouTube Web site. 
Retrieved September 29. http://youtu.be/YligIJY0RIg. 
64 Lung Cancer Alliance. 2012e. “2012 Lung Cancer Facts.” 
65 Gabriele Geier. “Personal Communication” November 8, 2013.  
  42 
 The campaign actually deploys ‘stigma’ as a common understanding of disease to 
tell a story of injustice toward individuals. This stigma framework refers to a certain set 
of assumptions and practices. Stigma as a framework attributes negative individual 
experiences to public attitudes. The connection of these attitudes with stigma is a 
significant connection because it characterizes these attitudes as inappropriate and unjust. 
Lung Cancer Alliance’s statements indicate that lung cancer patients are unjustly judged 
to be morally inferior due to society’s assumption that they have directly caused the 
disease from which they are suffering. Given the known risk of smoking, documented in 
the form of the Surgeon General’s warning since 1964 and suspected since the 1920s, 
today’s lung cancer patients are deemed the responsible agent for their disease.66 This is a 
unique situation. Few other cancers are understood in these terms. Since cancer is 
considered today as the result of a genetic mutation, the lung cancer patient is different 
because he is not the victim of a random biological accident but rather the major cause 
himself.67 The Lung Cancer Alliance’s argument is that difference, in terms of the 
patient’s role in the disease process, is judged by society and used as a vector to decide 
which claims the individual can make on society. LCA frames this phenomenon as 
stigma. LCA posits that this kind of exclusion, called stigma, has measurable negative 
effects. In a society that does not stigmatize lung cancer, those suffering from the disease 
would enjoy the benefits of more extensive scientific research; symbolic and financial 
support of the legislature; better access to early, low-dose computed tomography scans; 
and better overall care. As LCA pushes for change in society’s attitude about the disease, 
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67 Kleinsmith, Lewis J. 2006. Principles of Cancer Biology. Custom Ed. New York: 
Pearson, 69-72 
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the organization is also pushing for a different conceptualization and a new set of 
assumptions about what social and moral relationships the disease frame should encode. 
By emphasizing the patient aspect of the lung cancer patient’s identity and asking for 
society to understand individuals in this group in the same way as they understand any 
other individual with cancer, LCA is attempting to medicalize the disease. Their overall 
task is to shift lung cancer out of the stigmatized frame into the medical frame. However, 
what this actually means is flattened out by the simplicity of the campaign. While these 
tasks are implied by LCA’s campaign and supporting materials, they are never fully 
articulated, theorized, or explained. 
 In achieving its goals, the Lung Cancer Alliance’s campaign actually has three 
stages. In order to change perceptions, the campaign first has to identify the problematic 
perception leading to the exclusion of lung cancer patients. That perception and attitude is 
then proscribed and, finally society is instructed to view this group in a different manner, 
which I will call dissociating the disease from the diseased.  
   To satisfy the first requirement, the campaign frames the viewers’ understanding 
of lung cancer in terms of stigma. The campaign materials do not define stigma 
explicitly; the LCA Communications Manager states “We don’t have an explicit 
definition for ‘stigma.’ It’s the negative reputation that has lived with lung cancer for so 
long. It is a mark of disgrace or infamy; a stain or reproach.”68 Furthermore, the 
organization does not need to define stigma for the audience; it (correctly, given the 
impact of the campaign) assumes society has a working understanding of the implications 
of the concept. LCA paints the picture that society has a common-sense understanding of 
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lung cancer through the lens of difference and exclusion. This form of conceptualizing 
disease is the result of a common thought pattern in ‘normal’ society. The common 
reasoning pattern begins with comparisons between individuals or types of individuals 
that leads to a judgment of difference and allocation of a moral identity and rights based 
on those differences. The campaign makes it clear that it is wrong for the ‘normal’ viewer 
to have a negative attitude regarding a lung cancer patient’s sick status. As the focus of 
the campaign, this attitude is identified as a primary obstacle preventing progress in 
treatment and prevention of lung cancer. It is significant that public attitude is targeted in 
this campaign, shifting both the locus of responsibility and moral failure away from the 
patient and onto society. The “No One Deserves to Die” media materials present a clean 
presentation of the logical analysis, identity-making and categorization process that 
individuals in society often undertake when confronted with a new situation or re-
assessing a familiar one. In LCA’s formulation of the stigma frame, to pass judgment on 
a person with lung cancer is to inappropriately make a moral judgment regarding a 
situation that is less cut-and-dry than it appears.  
 A large body of epidemiological data shows that smoking causes lung cancer.69,70 
Many associate this fact with the idea that a single, clear cause for the disease exists. This 
idea, in addition to the fact that the cause is 100 percent avoidable, creates the public 
perception that the smoker is consciously, flagrantly ignoring the health risk. As a result 
of irresponsibility towards one’s own health, his actions do not warrant special 
consideration should negative consequences arise. It is his own fault if he gets lung 
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cancer. Furthermore, lung cancer has been a difficult disease to treat for many reasons, 
making the diagnosis of lung cancer equal to almost certain death. Following this logic, 
many have arrived at the conclusion: if one smokes and gets lung cancer, he deserves to 
die.  
 The deductive reasoning leading to this conclusion may stem from the 
psychological hypothesis of illness, as described by Susan Sontag, which states that 
people become ill “because they (unconsciously) want to” become ill.71 It is by will that 
the individual has chosen to become sick; such an individual, who has caused his own 
disease and willfully become a burden on others, deserves to be sick. The public logic 
expands on this hypothesis of illness and asserts that not only is this individual’s behavior 
the cause of the illness that he deserves, but also that he deserves to die for making this 
irresponsible psychological choice. Sontag explains that, “with modern diseases,… the 
romantic idea that the disease expresses the character is invariably extended to assert that 
the character causes the disease- because [the character] has not expressed itself.”72 If his 
will is to smoke, he cannot be redeemed from the almost inevitable death sentence of 
lung cancer because of the irresponsibility and immorality of his decisions, which is a 
direct reflection of his core self.  
 The “No One Deserves to Die” campaign mimics this type of deductive reasoning 
by applying injustice and difference to an arbitrary characteristic. In the situation 
constructed by the campaign, the viewer is making an initial assessment of the person by 
observing his/her appearance, behavior and general demeanor. For example, the viewer 
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sees that the man in the picture on the campaign poster has a beard and is wearing trendy 
accessories such as oversized glasses, a plaid scarf and a snapback hat. The features of 
the observed are compared with the viewer’s preferred form of those features. He 
identifies that this style is characteristic of the ‘hipster’ group. As a result, the viewer 
begins to think of the other features that characterize hipsters, perhaps the elitist attitude 
typical to most who identify as a hipster. Based on the viewer’s intuitive, rather than 
empirical or reasoned, perception of the individual, the viewer places the viewed on a 
normative scale of behavior and appearance. The viewer then adopts a negative attitude 
of the man in the campaign poster. Though this example may have only a weak 
connection to the moral character of the pictured individual, the process of judging moral 
character is the same, according to LCA. In the “No One Deserves to Die” advertisement 
materials, the audience is told that they do not prefer the features they observe in the 
provided image. Therefore, the audience is told that the characteristic is different, 
reprehensible, and reveals undesirable behavior and moral weakness. When judging 
someone with lung cancer, the viewer’s analysis determines that the individual is less 
worthy than those who previously exercised more responsibility for their health. As a 
result, the final judgment is that individuals who smoked ‘asked for it’ (lung cancer), and 
therefore, deserve to die. LCA considers this conclusion inconsistent. The audience is 
judging the hipster based on his outer appearance alone. LCA is drawing the parallel that 
society also judges individuals with lung cancer based on insufficient information and 
inappropriately attaches a moral identity to the individual. In this way, LCA brings forth 
a relationship between disease, identity-making and responsibility.  
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The television advertisement tells the viewer outright that “lung cancer doesn’t 
discriminate; neither should you.” This is to say that lung cancer does not only affect a 
single type of person; society should not discriminate against individuals on the sole basis 
of diagnosis with lung cancer. LCA wants to make it clear that a person’s identity is 
constituted by more than a single behavior. Classification by a single behavior, as a ‘cat 
lover’ for example, may tell others some information about the individual; however, this 
behavior does not directly indicate moral character. The campaign aims to recast people 
with lung cancer as ‘patients’ rather than deviants. When analyzing Western 
philosophers’ arguments about what makes character, Ian Hacking states that “the 
choices you make, situated in the thicket [of outside influences], are what formed you and 
continue to form you.”73 Based on this idea, character is not a fixed entity. Therefore, the 
person as presented in a particular context, such as provided through the “No One 
Deserves to Die” campaign, does not indicate who he truly is, was or will be in the future.  
 Not only is discrimination as a result of a single fact about a person unacceptable, 
but asserting a punishment on that basis is morally unacceptable.  The campaign moves 
beyond identifying the source of injustice stemming from society’s commonly held 
perceptions, to also proscribe society’s negative, ill-informed reactions. In this way, the 
campaign extends itself to directly confront the stigmatizers’ attitude toward the 
stigmatized. Not only does the campaign oppose identification of those with lung cancer 
as ‘deviant,’ this stage of the campaign is asserting that devaluing this group is outside 
the appropriate range of responses. In this way, the campaign’s major function is actually 
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defining appropriate social attitude for stigmatizers rather than boost the image of the 
stigmatized patient. LCA aims to transform the viewer’s attitude from negative into a 
tolerant attitude that rightly views the person with lung cancer as a patient in need of 
compassion and care. By shifting away from previous labels of ‘immoral and 
irresponsible,’ toward ‘patient’ the hope is that some of the negative connotation will fall 
away and alleviate the injustices LCA seeks to correct. To frame lung cancer in terms of 
a biological anomaly, rather than the consequence of a voluntary behavior, removes the 
moral responsibility for the disease.  
 Medicalizing lung cancer as a solution for reframing stigma is interesting. Stigma 
and medicalization offer different ways to view the same issues. Each frame carries 
expectations about the individual’s responsibilities and the space he should occupy. 
Traditionally, medicalization has been viewed in social theory as an inappropriate 
application of medical solutions to a social problem. However, the medical viewpoint is 
desired in order to recast lung cancer as a biological disease, rather than a moral failing. 
Lung Cancer Alliance implies that this is a case that should be considered from a medical 
perspective; lung cancer should exist in a medical space, that addresses the social 
problems associated with lung cancer. However, a medical framework does not remove 
all social aspects of the problem. Shifting the frame toward the medical view carries 
implications for the way the patient exercises his rights and what rights he has. The 
medicalization literature of the 1960s and 70s viewed the phenomenon as a measure to 
legitimate the medical profession at the expense of the individuals’ rights. Medicine 
establishes its own norms; the expectation that a patient comply with all reasonable 
treatments becomes the yardstick against which all patients are measured. Should he 
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fulfill this patient role, he can legitimately make claims on the medical community for 
care. If he does not fulfill his patient role, he is identified as non-compliant, and has a 
diminished ability to make claims on the medical community. Ultimately, medicalizing 
public attitude about lung cancer characterizes the individual with lung cancer as a 
patient and shifts responsibility back to the patient for managing his disease. 
   
V. Dissociate the Disease from the Diseased 
 Goffman states, and Minow supports, the idea that social interaction is made 
uncomfortable when difference is presented in an unexpected way. Lung Cancer Alliance 
knows this and adopted this strategy. The “No One Deserves to Die” campaign has made 
society question their preconceived notions. It made us uncomfortable. It made us 
question what it means to have a disease that we are not allowed to ask for help in order 
to manage it.  
 The Lung Cancer Alliance case brings forth important features of understanding 
disease in the stigma framework. The non-profit organization proposes the concept of 
stigma as a given, a closed thing that exists. Whereas what they are really doing is 
asserting stigma as not only a possible a way of understanding the disease and response, 
but also the way that we actually understand and frame the problem of injustice and 
negative attitude about lung cancer. This kind of attitude about a disease is problematic 
because the patient’s health and identity suffer as a result. LCA’s hypothesis is that 
confronting and removing this negative attitude would allow patients to be more open 
about their disease, stimulating conversation and awareness. The “No One Deserves to 
Die” campaign calls this phenomenon ‘stigma’ and uses this framework as a way to bring 
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forth a relationship between disease, identity- making and responsibility. LCA asserts 
that the constructed identity is a key method causing injustice to lung cancer patients. 
This leads me to question how this relationship is made, given that Lung Cancer 
Alliance’s stigma narrative flattens out the relationship between disease, identity making 
and responsibility? Given this shift from stigmatization toward medicalization and the 
mission of destigmatizing lung cancer, my original hypothesis was that medicalization of 
a disease, or understanding the disease in objective medical terms, would necessarily 
entail elimination of stigma and normative judgments of the disease and the person living 
with the disease. It turns out the idea that medicalization equals destigmatization is an 
oversimplification of how social problems are understood and framed. And, how is the 
perspective of those issues shifted by medicalizing the problem of injustice toward lung 
cancer patients? LCA proposes that devaluation of those with lung cancer should be 
addressed by medicalizing the problem, so as to correct the marginalization that lung 
cancer patients currently experience. In the medical space, LCA seems to hypothesize 
that judgment of character is de-emphasized, potentially allowing lung cancer to be 
regarded as equal to any other cancer. In the medical framework, it is thought that public 
perception of lung cancer becomes objective. LCA posits that this shift will change the 
nature of the problem and promote awareness and increased research funding. In this 
way, lung cancer can overcome the injustices that have prevented it from garnering the 
support that other cancers have received.  
 Instead, these two frameworks emphasize the same things, but in different ways. 
Both frameworks describe a relationship between identity, responsibilities of society and 
a disease. Stigma and medical frameworks of disease each offer a method to explain 
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difference. Yet, the norm is encoded in both of those constructions of difference. The 
norms lead to expectations of the patient. Each frame implies individual responsibility in 
some manner. Each framework also provides a tool for exclusion and inclusion. By 
categorizing the patient in each frame’s respective terms, the individual is identified in 
terms of the space he should occupy. Additionally, each frame acts as a justification for 
allocation of rights. In the frame LCA calls ‘stigma,’ lung cancer patients are excluded 
based on their difference from other patients. These patients are not able to make claims 
on society for more research dollars or better care. By medicalizing the disease and 
shifting the frame, lung cancer patients take on an active responsibility for their disease. 
It is his role, as a patient, to comply with reasonable medical treatment. This can be 
considered a procedural responsibility; the patient simply has to follow through with the 
prescribed treatments and interventions at the appropriate times. Should he do this 
successfully, he has earned the label of patient. He is then able to make claims on the 
medical community for further care and on larger society for funding to enhance research 
benefitting his disease. With this possibility, responsibility is assessed both passively and 
actively . These lower level negotiations by the patient, medical community and society 
help draw out the larger picture. The relationship between disease, identity-making, and 
responsibility as seen in these frames become ways to operationalize difference. 
Difference becomes a tool for exclusion or inclusion which is a common feature of both 
the stigma and medical frame. Each of these frames, however, assess difference in its 
own manner. Because of this, the moral aspect of disease is understood differently in 
each frame.  
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CHAPTER 4 
THE STIGMA FRAMEWORK 
I. Introduction 
 Lung Cancer Alliance’s “No One Deserves to Die” advertising campaign reveals 
a relationship between disease, identity-making and responsibility. Analysis of this case 
serves as a tool to examine this relationship as it relates to the underappreciated moral 
aspects of disease. Given the analysis of the case, and Lung Caner Alliance’s focus on the 
stigma and medical frames, it is useful to examine these frames. I will explore these 
frames in order to understand the aspects that are collapsed in the “No One Deserves to 
Die” campaign in the following two chapters. A fuller understanding of what these 
frames actually signify will provide a clear explanation of how and where these 
relationships are made. In this chapter, I ask, given that Lung Cancer Alliance’s stigma 
narrative flattens out the relationship between disease, identity making and responsibility, 
how is this relationship made? By this I mean, what foundational interactions generate 
the relationship between disease, identity, and responsibility, which is highlighted by 
Lung Cancer Alliance? The theoretical analysis in order to answer the question will 
enliven the intricacies of this relationship LCA points to in its campaign. This chapter 
examines the concept and framework of stigma as developed in sociological literature in 
order to understand the connections between disease, identity-making actions, and 
responsibility. LCA suggests that stigma is a given. LCA discusses the problem of stigma 
as a problem of public attitude. But what are the collectively held meanings of stigma that 
LCA is dipping into in order to get stigma to connect disease, identity-making and 
responsibility in the campaign? Treating negative public attitude as a given ignores the 
  53 
work that goes into creation of the attitude. Review of sociological literature highlights 
concrete social behaviors that contribute to the problematic public attitude LCA directly 
confronts in the “No One Deserves to Die” campaign. By calling it stigma, LCA is 
referring to a set of problematic social relationships. The organization’s exploitation of 
stigma tells us something about the common- sense meaning of stigma vis-à-vis disease.  
I would like to use this concept as a tool for analysis to pull these relationships apart.  
 LCA tells the story of lung cancer as a narrative of stigma. LCA suggests the 
problem of public attitude, which they frame as stigma, can be remedied by shifting 
toward a medical understanding of lung cancer. Therefore, the same question is asked in 
relation to the medical frame in the following chapter. Another question will also be 
asked in the following chapter: how is the perspective of the problem of injustice toward 
lung cancer patients shifted by medicalizing the relationship between identity-making, 
disease, and responsibility? The theoretical analysis in these two chapters will be used as 
tools in order to provide a clear explanation of my overarching line of inquiry into the 
moral aspects of disease. 
 In Illness as Metaphor, Susan Sontag focuses on the social meanings TB and 
cancer carry even after historical basis for those meanings fell away. The lingering 
meanings leave society with identity markers, but little understanding of their origin. 
When it is unclear why a certain group is blamed for a disease, explanation degenerates 
to a pre- reflective “that’s just how it is.” Because stigma is a discrepancy between 
expectation and reality, as Goffman describes, the application of the concept is unique in 
each situation. Health conditions are tractable surfaces to attach stigma because, health 
and disease is normalized by medical knowledge. The stigma carries the meaning that the 
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stigmatized does not conform to the normal health regimen. Those with a certain health 
issue are different enough from others in his social circle that it feels justified to the 
group to judge that the individual’s deviance from their norm is unacceptable. In his 
discussion of disability and the Civil Rights Movement, Joseph P. Shapiro states that 
“fear, disabled people understand, is the strongest feeling they elicit from nondisabled 
people.”74 He continues on to describe that the stigmatized attribute reminds the viewer 
or the other of the uncertainty of his relatively ‘healthy’ condition. In this way, fear fuels 
stigma. People tend to expect to be healthy indefinitely, however, the reality is that our 
healthy state is transient at best. The transient quality is undesired and if we fight against 
it, we can extend our health as much as possible. Thus, those who succumb to ill-health 
early can be seen as someone who did not fulfill his duty to his health. Not only is this 
outside the social expectation that the citizens maintain their health, but it calls into 
question a ‘normal’ individual’s responsibility toward health. As proof that regular 
exercise and healthy diet are good for an individual, but not necessary for survival, it 
calls others’ behavior into question.  
 Charles Rosenberg describes several diseases for which meaning is ascribed based 
on the disease history and the patient experience beyond the literal, clinical definition of 
the disease. The disease frame is constituted by the disease history and the lived 
experience, which society responds to based on a disease-specific set of assumptions. 
These boundaries for the disease frame are essential for understanding the identity of the 
individual as a patient. His analysis summarizes the importance of place and time in 
framing disease and postulates that the literal biological nature of the disease also 
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contributes to the frame that results from intellectual work regarding a disease.75 
According to Rosenberg, the diagnosis is an important step that sets up the initial frame 
of the disease. A stigma framework of disease emphasizes identity-making and 
responsibility as key components contributing to the moral aspects of the disease. The 
stigma framework takes on slightly different characteristics in relation to specific disease 
as a result of unique disease history. In the same vein, the appropriate intervention on a 
stigma framework is unique to the disease being framed.  
 Lung Cancer Alliance has operationalized stigma in such a way that describes the 
relationship between lung cancer, identity and responsibility. LCA’s campaign collapses 
this relationship, which they frame as stigma, in a way that glosses over the social actions 
that create a stigmatized understanding of disease. The campaign ignores how public 
attitude about lung cancer was made. Society’s actions (comparing types, assessing 
difference, and allocating rights on that basis) classify its understanding of disease within 
the definition of stigma. The definition of stigma has evolved over time. The changing 
definition also reveals a historical shift from stigma as a concept in social theory to 
stigma widely used as a framework for understanding social interaction with disease.  
 
II. Definition and Ambiguity: Features of a Stigma Framework 
 Erving Goffman’s 1963 book, Stigma: Notes on the Management of Spoiled 
Identity, provides a thoughtful discussion of what stigma means, in terms of definition, 
individual management and group negotiation of the concept. Erving Goffman is one of 
the most frequently cited sociology scholars who dealt explicitly with the concept of 
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stigma. His characterization of stigma has made a large contribution to the field of 
sociology generally, and understanding the social experience of disease specifically. 
Goffman describes stigma most succinctly in the preface of Stigma when he describes it 
as “the situation of the individual who is disqualified from full social acceptance.”76 He 
also defines stigma alternatively as “an attribute that is deeply discrediting,” an 
“undesired differentness from what we had anticipated.” 77 It is because of this difference, 
this deviance from the norm, that the stigmatized individual is “reduced in our minds 
from a whole and usual person, to a tainted, discounted one.”78  
 As we move through other definitions, the concept is shifted away from 
Goffman’s original formulation of stigma. Gerhard Falk states that stigma “occur[s] 
whenever and wherever some people find behavior or characteristics of other people 
offensive and/or reprehensible.”79 Anne Hendershott defines stigma as “a powerful 
negative label that fundamentally changes a person’s social identity and begins to operate 
as a master status.”80 Goffman would disagree with this definition; he notes that the 
attribute itself is amoral, rather the social response to the attribute is the force that 
attaches a moral implication to the attribute. Ian Hacking states that a realist would argue 
“the disease itself is an entity in its own right, independently of how we classify it.”81 
Similarly, the realist may argue that behavior is carried out regardless of what it is called 
or the moral judgments made about that behavior. Whereas the nominalist would argue 
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that identity of things and people is entirely constructed and, thus, is not based on the true 
nature of that entity.82 Hacking  argues for dynamic nominalism, in which both of these 
actions occur simultaneously. If “the category and the people in it emerge hand in hand,” 
then the label and the nature of the attribute both contribute to the resulting identity. 
Rosenberg explains this connection with his statement that, “in our culture, a disease does 
not exist as a social phenomenon until we agree that it does.”83 Therefore, labeling is both 
a driver of social reality, and a result.84 Inconsistencies such as these in the definition of 
stigma as a concept is repeated functionally when stigma is deployed as a framework for 
understanding a disease without first clarifying its relationship between the disease and 
the moral identity it is said to describe.  Though a general consensus about the definition 
of stigma has been reached, there is no single, all-encompassing definition of  stigma. 
 As one progresses through the definitions of stigma, a shift from concept as a 
neutral mark to a normative entity of underlying character becomes visible. Goffman 
postulated a definition for the concept of stigma in itself in 1963. In his definitions, 
stigma is a “situation” or “difference” which are objects modified by adjectives provided 
through social response. He notes that the attribute itself, causing stigma, is amoral; 
rather the social response to the attribute is the force that attaches or removes value from 
the individual carrying that attribute. He states this reflects the Greek definition that 
indicates the individual is a physically “blemished person.”85 In 1978, Susan Sontag 
described that stigma is applied to a disease by attaching the disease with metaphors 
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which connect the appearance of the disease with the character of the diseased.86 In this 
way, the underlying character of the individual is emphasized over the physical attribute 
associated with stigma as the definition moves away from the Greek formulation of 
identity. In 1988, Sontag cites Goffman’s “spoiled identity” definition of stigma in AIDS 
and its Metaphors, and declares society has moved away from this formulation of stigma 
as applied to cancer. Cancer has become less feared, and therefore, less burdened by 
stigma.87 She states “cancer is treated with less secrecy” in recent medical practice. In 
addition, AIDS (Acquired Immunodeficiency Syndrome) is the new disease “identified 
with evil, and attaches blame to its ‘victims;’” there can only be one such disease after 
all.88 Given Sontag’s explanation, lung cancer should not be understood in terms of 
stigma. However, fear is not the only social aspect of identity-making that can be 
understood in these terms. Definitions proposed in the 2000s follow Sontag’s trend 
toward including social aspects of the concept. Falk’s definition in his 2001 book 
emphasizes the social response to ‘the mark,’ which is colored in negative language. 
Hendershott’s 2002 definition explicitly states that stigma is a “negative label” that 
overtakes one’s identity such that he is the label, and nothing beyond it. Furthermore, 
normative response to a specific personal feature is not universal; it is subject to time, 
place, social context.89 Therefore, the negative label Hendershott describes does not 
always apply. I include her definition because a) it explicitly includes the concept of 
identity, and b) it seems to capture the perspective of the individual living with stigma. 
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The intellectual definitions are structural, whereas her iteration speaks to the lived 
experience. Link and Phelan state that each discipline may offer a diverse understanding 
of stigma. Sociological literature provides a better understanding of the components that 
Link and Phelan describe in their definition of stigma: the co-occurrence of its 
components—labeling, stereotyping, separation, status loss, and discrimination.”90 I find 
the separation of these aspects to be somewhat artificial, and will discuss them in terms of 
a combination of Martha Minow’s “difference dilemma” and Goffman’s discussion of 
professional presentation of stigma and the concurrent implications for responsibility.  
The progression through definitions of stigma begin to reflect how public attitude about 
disease is formed. The following discussion will continue to break apart the discrete 
social actions these theorists point to which form the relationship between disease, 
identity-making and responsibility that the “No One Deserves to Die” campaign brings 
forward.  
 
III. Concept to Framework 
 As the definition of stigma shifts toward a normative assessment, a parallel shift 
from concept to framework also occurs. By taking normative actions based on the 
definition of stigma, this concept is enacted as a way of understanding and responding to 
a disease. Furthermore, the connotations the definition has accumulated (the negative 
connotations in this case) influence the way in which the concept is applied. The 
negativity that often accompanies stigma signifies a major public assumption that the 
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person who is stigmatized is bad and deserving of such negativity. Encoding the very 
definition in this way pigeonholes stigma’s use, providing a limited understanding of 
those to whom it is applied. Lung cancer, in this case, is therefore understood and 
responded to in a specific way within this framework of stigma. By asking the question at 
the beginning of this chapter in a slightly different way, what does Lung Cancer 
Alliance’s use of stigma tell us about our cultural common sense about disease frames?, 
the literature reviewed here and above show that a normative judgment about the 
individual has become our common sense understanding of disease frames. This limited 
progression from a widely cited definition of a concept toward a normative framework is 
only one side of the story; it is likely that the definition of the concept/framework shifted 
in response to common application of the concept. An in-depth genealogy that examines 
the emergence and interdisciplinary understanding of the concept/framework would be a 
rich area of future research, though is beyond the scope of this project. Such an 
understanding of how stigma became a tool to understand social interaction, especially in 
relation to one’s disease status, would have diverse applications across history of 
medicine, clinical practice and public health. But for my purposes it is sufficient to note 
that, Lung Cancer Alliance’s use of stigma as a framework is legitimated by the very 
evolution of the definition and practical application of the concept of stigma to disease.  
 
IV. Comparing and Judging Difference 
 As stigma has become connected with specific assumptions, and in turn become a 
normative understanding of disease, it becomes clear that norms are embedded in public 
attitude. The “No One Deserves to Die” campaign glosses over how this public attitude is 
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made. When a group like LCA states stigma exists, with little theorizing about the precise 
social interactions they are characterizing, the creation of stigma is a given. LCA does not 
explain how a stigmatizing attitude comes to pass. In their employment of the term, it just 
is. As I have explained in the previous chapter, LCA problematizes this attitude in terms 
of stigma. LCA tells the audience that it holds a negative public attitude about lung 
cancer. LCA does not explain how such a public attitude came to be. The group is 
emphasizing the effects of understanding a disease in terms of stigma. The LCA case 
shows that, for the concept of stigma to apply, and for it to frame social relations in the 
terms outlined above— from comparison and difference assessment to attaching a moral 
valence and allocating rights and responsibility on that basis— its framing effects need 
not be explicit or recognized. By asserting that stigma exists, and eschewing the work to 
convince the audience that it is so, LCA positions the audience as stigmatizer. LCA 
thereby opens the door for stigma to be a mode of characterizing the social position of the 
diseased. Stigma and the process it refers to, then, plays a large role in identity-making. 
 The literature shows that one does not inherently fit a norm, as the common sense 
nature of the campaign suggests. Martha Minow discusses that discrete social actions 
must occur to classify an individual as normal or other. In order to determine if one fits 
the norm, he must be compared to that norm. When some feature of his identity goes 
against the expectation, he is judged to be different. As a result, space is made for new 
identities. This process is not merely a naming process reflective of a passive truth, but 
rather a “dynamic nominalism,” says Ian Hacking, in which “the category and the people 
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in it emerged hand in hand.”91 Not only does it frame one’s identity, but it creates new 
possible identities, according to Ian Hacking.92 Characterizing labeling this way makes 
Charles Rosenberg’s argument that “every aspect of an individual’s social identity is 
constructed” more robust.93  
 As a particularly significant point, Martha Minow states that difference becomes 
problematic when it functions as a set of “unstated assumptions.”94 Difference becomes a 
feature where rights are assessed inappropriately when difference is assumed: to be 
intrinsic; in relation to a norm that does not need to be stated; able to be assessed without 
influence of perspective; without input from other perspectives; and, based on a status-
quo that is natural and good.95 In her formulation, a comparison leads toward a 
diminished identity that can be marginalized when comparisons between types of people 
are made with no acknowledgment of the bias or perspective of the observer. As a result, 
the difference “pigeonhol[es] people in sharply distinguished categories based on selected 
facts and features.”96 In this way, the difference is made to seem a true feature of their 
identity, whereas, it is really a reflection of the perspective of the observer. 
 When difference is the background, a normative judgment of the individual is 
then made. From the lung cancer example, it is clear that the lung cancer patient is 
assumed to have a role in causation of his disease. In this way he is different from other 
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cancer patients. Thus, judgment identifies him as a risk-taker, unworthy of the benefits 
other cancers enjoy. The “characteristics that are deemed socially significant” are the 
interesting sites where difference is framed as stigma.”97 Characteristics become socially 
significant when a comparison yields difference that departs from an acceptable 
spectrum. 
 These differences highlighted in the newly created identity can be explained by 
employing normative claims about the individual as the identity is recognized and 
negotiated by society. Goffman might describe the addition of normative claims about a 
neutral label in terms of stereotyping. A stereotype is understood as an identity 
commonly given to a certain group of people with the assumption that it accurately 
describes those people; often with the intention of applying an analysis of the person 
rather than simply labeling that person. I find the concept of a stereotype problematic in 
practice as stereotypes tend to linger beyond their usefulness. Indeed, a stereotype is a 
type of identity that captures a picture of society at a specific moment. It infuses a 
particular value held by society at a certain time into a classification of a person. Because 
a stereotype tends to be a static entity that is broadly applied, it does not seem to match 
Hacking’s description of the dynamic features of framing or identity making. Relying on 
stereotype seems to limit the possible categories an individual can occupy. Link and 
Phelan hint at this when describing a stereotype as a way to “make shorthand decisions” 
about other people so as to avoid spending too much time or reasoning power on trying to 
categorize others.98 The Lung Cancer Alliance case demonstrates that flattening 
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differences in this manner causes more harm to the patient than benefit provided to 
society. In the case provided, the norm is encoded in the construction of difference. 
Martha Minow explains that this occurs because “reasoning processes tend to treat 
categories as clear, bounded, and sharp edged… instead of considering the entire 
individual, we often select one characteristic as representative of the whole.”99 The 
identity resulting from the perceived difference goes beyond a flat perception of a type of 
person, and becomes an object to be categorized as ‘normal’ or ‘other.’ By creating a 
category for a person that is not whole, it more clearly defines those that can be 
considered whole. 
 Separation on the basis of difference is justified in the social consciousness based 
on deviance from the norm, the third defining piece of stigma. Anne Hendershott 
explains the body of classical deviance literature shows agreement that deviance is “the 
social pressure to conform and be normal.”100 Her analysis of Erving Goffman concludes 
that he characterizes deviance as a “consequence of acquiring a stigma;” an identity that 
is applied after the individual is discredited.101 On the surface, this conflicts with Link 
and Phelan’s definition of stigma, which implies that deviance, in the form of separating 
types of people, contributes to the resulting stigma framework applied to a group or 
individual. Based on their definition, a stigmatized understanding of the disease results 
from separation by defining two different types of people. The act of defining a deviant 
includes defining who does not fit within the frame designated “normal;” this could also 
be described as the act of conceptually creating categories in which to place people. The 
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new category of people is then discredited on the basis that they are the type of people to 
occupy that category. Link and Phelan’s definition does not specify whether defining 
people or defining categories contributes to the stigma frame. It may be impossible to 
make that distinction and serves as an example of Hacking’s argument that the label and 
the category simultaneously contribute to the stigma framework.  
 Making such a distinction between a whole and compromised identity leads to 
new responsibilities for the sick individual who is not considered whole. Sontag suggests 
that he is burdened with “the ultimate responsibility both for falling ill and for getting 
well.”102 The stigma framework does not provide a clear idea of how the patient should 
take responsibility for getting well. Goffman describes how the individual can take 
responsibility for falling ill though. He states that the stigmatized appropriately fulfills his 
role when he walks a fine line between concealing his stigmatizing feature in public and 
having reached a level of personal acceptance of that feature such that, when it is 
revealed in public, it is easy for ‘normals’ to offer acceptance.103 Goffman calls this 
social expectation “good adjustment” and the one that carries this out the “gentleman 
deviant.” Good adjustment is demonstration that the sick individual is holding himself 
responsible for falling ill by bearing his stigma honorably, without letting his difference 
embarrass those around him. Meanwhile, the “gentleman deviant” himself, one who is a 
“nice person like ourselves in spite of the reputation of [his] kind” is never expected to 
leave this liminal space, but rather toe this line until his stigma disappears (if ever). To 
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reject this and attempt to become fully “normified”104 would be indicative that the 
individual is not accepting responsibility for falling ill. He is being dishonest with himself 
and to society about his shortcoming.  
 Conversely, Lung Cancer Alliance emphasizes society’s responsibility. LCA skips 
over the theoretical argument that an individual with lung cancer should take 
responsibility for his disease. In doing so, LCA partially absolves lung cancer patients’ 
individual responsibility for the disease and places responsibility for the negative disease 
identity attributed to lung cancer with larger society. Because society’s perceptions of 
this group are unfounded, society is at fault for casting lung cancer patients in a negative 
moral light. Society is responsible for diminishing lung cancer patients’ rights, or ability 
to make claims on society, to representation in medical research and care. By 
representing lung cancer patients as victims of societal misperception, LCA is “making 
consistent sense out of [the] situation” and professionally presenting individuals with 
lung cancer in Goffman’s terms.105 LCA acts in an authoritative capacity to officially 
manage the identity of individuals with lung cancer in their place. LCA suggests lung 
cancer patients should be understood as patients. The expectation is applied in two ways. 
First, it applies to larger society, asking that it change its attitudes about lung cancer 
patients. Second, in order to for lung cancer patients to be understood out of the context 
of a moral valence, they become responsible for assuming a new role. In some ways, 
LCA’s organization of lung cancer patients as a group absolves the group of the moral 
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responsibility that the framework of stigma is build upon. Yet, LCA’s suggestion that 
lung cancer patients should be considered patients rather than moral deviants indicates 
that patients are responsible for their disease in a new way. The argument that CT 
screening and high- level medical care be available to all indicates that the patient (or 
potential patient who is ‘at risk’) should accept a medical understanding of the disease.   
 
V. Rights and Difference 
 LCA’s minimalist campaign glosses over all theoretical contributions to the 
concept of stigma. By glossing over the identity- making interaction that include 
comparison, attributing difference, and making normative judgments, LCA allows the 
origins of society’s problematic, negative attitudes toward a group like lung cancer 
patients to go unnoticed. Letting the complexities of this process go unstated, LCA’s 
invocation of stigma implies society has undergone this identity- making process. Yet, 
the process itself goes unexamined. Take for example the assertion that an individual, or 
group of people, “deserve to die.” This statement is based on an interpretation that the 
stigmatized individual committed some reprehensible behavior for which he should bear 
the consequences. This example implies the individual is resigned to a less worthy life, 
one that should not continue. If it is the case that the distinction between a life that should 
continue, and a life that should not continue comes before the specific discrediting 
feature or behavior, then the stigmatized group’s identity is based on society’s 
devaluation of that feature/behavior. Specifically, the value that nonconformity, 
especially in the form of risk taking behavior, deserves punishment. Those who enact the 
discrediting behavior are then moved into the stigmatized category and become worthy of 
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punishment. They are not only subject to punishment, but a diminished claim for life. 
Conversely, a feature or behavior that disqualifies members of a group from claiming full 
personhood could contradict society’s values and constitute the boundaries of a new 
available category in which to place people. If these two situations happen 
simultaneously separation and label making contribute to an identity that has a 
diminished right to make claims than the rest of society; this group of people has lost 
their right of life. Based on the interaction of separation and label-making, the resulting 
stigma effectively denies rights to groups and individuals. Given that it is not uncommon 
to hear that someone deserves to die, especially in relation to a disease for which there is 
a known health risk, we can conclude that separation based on this attitude is accepted in 
society to some extent. Even when the group is made up of “gentleman deviants” who 
demonstrate “good adjustment,” the social response may be less dichotomous, yet stigma 
remains. The group is still labeled as those who exhibit behavior against the norm.  
 The organization implies that society has undergone this process of identity- 
making. Going unexamined, the theoretical process is glossed over. However, these 
theoretical concepts build an identity which becomes the basis for which individuals are 
ascribed certain responsibilities. This connection is simplified to a fault in the Lung 
Cancer Alliance campaign, but it is an important driver of public attitude. Comparison, 
assessment of difference and normative judgment are important aspects of social 
interaction that significantly shape the relationship between disease, identity-making and 
responsibility. Lung Cancer Alliance is referring to these social actions when it says 
‘stigma.’ The problematic public attitude about lung cancer can be traced back to these 
social actions. It can be traced even further as a negative moral judgment became 
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embedded in the definition itself. Framing the disease in terms of stigma, when that 
means society’s (often unconscious) reasoning about those individuals is colored by a 
moral calculus, again encodes a general attitude about the group. Because the encoded 
attitude is negative, marginalization follows the normal response to an unworthy group. 
Traditional sociological text suggests the individual is responsible for accepting and 
changing his disease. The stigma framework does not provide a clear way for the 
individual to manage his disease identity moving forward. Lung Cancer Alliance 
absolves the individual with lung cancer of any responsibility for his current situation. 
This position follows the logic that “as long as disease is something that takes possession 
of people, something they ‘catch’ or ‘get,’ the victims of these natural processes can be 
exempted from responsibility for their condition.”106 Instead, LCA places blame on 
society itself for stigmatizing the patient. Lung Cancer Alliance offers the medical 
framework as a solution that purportedly reaches for moral neutrality, and offers a clear 
method for the individual to take responsibility for his disease moving forward.  
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CHAPTER 5 
MEDICALIZATION 
 
“Health has ceased to be a native endowment each human being is presumed to possess 
until proven ill, and has become an ever receding goal to which one is entitled by virtue 
of social justice”107 
 - Ivan Illich, Medical Nemesis: The Expropriation of Health 
 
I. Introduction 
  Lung Cancer Alliance proposes that the public attitude and understanding 
of lung cancer should be medicalized. The injustices that LCA emphasize, especially low 
federal research funding and high mortality rate, stem from a lack of attention from the 
medical community. LCA seem to indicate that shifting public perception of the disease 
to be framed in terms of a medical problem would garner more funding and create 
structural support for the lung cancer patient. The call for a shift itself implies both a 
failure (by society) and a remedy. The proposed remedy draws on the medical frame to 
reorganize society’s problematic attitude. Therefore, the relationships that help build the 
public perception are medicalized. The medical framework is a solution for LCA that 
would diminish the moral aspects of lung cancer and ease the injustice individuals with 
lung cancer are currently experiencing. LCA’s picture of what it means to destigmatize 
lung cancer is revealed by appealing to the medical frame. How is the perspective of the 
problem of injustice toward lung cancer patients shifted by medicalizing the relationship 
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between identity-making, disease, and responsibility? After a review of the definitions of 
medicalization from the sociological literature, and a brief overview of the history, I will 
use LCA’s call for medicalization as a tool to understand the relationship between 
disease, identity-making, and responsibility in the medical frame. The same reasoning 
that contributes to this relationship in the stigma framework applies here, with some 
alterations. Rather than beginning with a comparison intended to categorize the person, 
the individual is initially placed in the patient category until he proves himself unworthy 
of that title. Based on assessment of his active responsibility toward his care, he is either 
allowed to remain a patient, or is considered non-compliant and his patient identity is 
‘marked’ or diminished. As such, the patient’s identity and responsibility for his disease 
are intertwined in a more complex fashion. This complexity is ignored in LCA’s 
recommendation that public attitude is shifted to a medical understanding of lung cancer. 
Thus, I argue that the moral aspects of disease do not seem to be removed as LCA 
suggests. 
 
II. Definition 
The definition of medicalization has changed since the term was first applied in 
the mid- 1900s. It is generally accepted that medicalization, in its most bare definition, 
means ‘to make medical,’ indicating a social problem is being considered with a medical 
viewpoint. However, an interesting discussion has arisen out of the more complete, 
working definition. As meaning has been ascribed to the term, its definition has changed 
and reconstructed in a few different ways. Peter Conrad, an American sociologist, states: 
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“Medicalization consists of defining a problem in medical terms, using  
medical language to describe a problem, adopting a medical framework to 
 understand a problem, or using a medical intervention to treat it. This is a  
sociocultural process that may or may not involve the medical profession,  
lead to medical control or medical treatment, or be the result of intentional  
expansion by the medical profession.”108  
 
A similar definition provided by Peter Whelig et al. in a letter to the editor of the 
German/English bilingual journal Deutsches Ärzteblatt International highlights that the 
‘problem’ is a social phenomenon. They state “Medicalization is a process by which a 
social phenomenon that to date was not perceived as medically relevant now becomes 
defined by medical terms and/or treated with medical means.”109 This definition provides 
a clearer picture of what Peter Conrad spends a great deal of effort to explain in his 
article in the Annual Review of Sociology. The emphasis of these definitions is the 
process of applying medical knowledge to a non-medical problem. Conrad’s 1992 
definition quoted above emphasizes the conceptualization of a social problem as a 
medical problem. Whereas, in 1975, Conrad’s definition includes to an equal degree the 
idea that medicalization means a social problem is framed as a medical problem, and idea 
that this frame appropriately places the problem within one of the medical field’s many 
roles. The 1975 formulation of the definition stated medicalization meant “defining 
behavior as a medical problem or illness and mandating or licensing the medical 
profession to provide some sort of treatment for it.”110 The latter half of the definition is 
key, indicating that the medical field is imposing its authority on the treatment or 
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management of the problem. This is referred to as the “jurisdictional aspect” by Joseph E. 
Davis. Drew Halfmann agrees with Davis, both contending that the ‘jurisdictional 
aspect,’ which was later removed from the definition, was an important feature, necessary 
for understanding the concept. 
The criticisms regarding the redefinition of this phenomenon posed by Halfmann 
and Joseph E. Davis center on the idea that medicalization needs to be understood in its 
full medical context; by changing the definition, the true meaning of the process is lost. 
Davis contends that the inclusion of the jurisdictional aspect in the definition provides a 
sense of the boundary between legitimate and “illegitimate extensions” of power by the 
professional medical field. The removal of the implied boundary removes the problem 
medicalization poses, which is the problem of inappropriate application of medicine and 
the medical framework to everyday life. Davis further criticism lies with the loss of 
control over the use of the medical frame. The new formulation of the definition becomes 
open to “any group or individual’s use of such terms/frameworks,” which he finds 
problematic because “outside the sphere of medicine, we have no way to determine what 
constitutes a ‘medical’ term or framework.”111 In other words, the ability to frame a 
problem as a medical one provides a new way to characterize problems that may arise 
and, therefore, a new way to categorize the people those problems affect. While criticism 
that removing the jurisdiction component from the definition takes away from the 
concept of medicalization, understanding of the ways in which other types of groups use 
medicalization would provide important cultural knowledge. As I will discuss later, the 
way in which a ‘medical term or framework’ is used highlights influential sources of 
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knowledge. Those sources contribute to a patient’s understanding of his/her illness the 
resulting shift in identification after diagnosis. Explicating the factors that shape the 
social context is an important task since “what qualifies as biological disease or 
biomedical evidence is often socially negotioated and interpreted.”112 
Though Davis and Halfmann have a strong basis upon which to reject the newer 
definition of medicalization, I will use the definitions that emphasize adopting a medical 
frame to understand a social problem in this discussion as I try to understand the nature of 
the social forces surrounding medicalization. However, I will not discount the earlier 
definition; the evolution of the definition is important to provide a complete picture of the 
concept. The spirit of the 1975 definition is in line with the criticism of medicalization 
popular during the time period. Robert A. Nye points out that skepticism of the “medical 
model” at that time captured a tension between patient’s higher expectations and more 
sophisticated demands, and the profession’s desire for control.113 As we move forward 
into more recent history, other contributing factors come to light. 
 
III. Levels of Medicalization  
 There are several proposed systems for understanding the spectrum 
medicalization. Drew Halfmann discusses the typology of medicalization proposed by 
Conrad and Scheider and proposes his own typology. Central to his proposal is the idea 
that the level of medicalization increases or decreases in response to social and scientific 
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variables. This is significant because scholarly literature often treats medicalization as a 
dichotomy; that it either does or does not exist.114 The typology Halfmann proposes 
includes three dimensions of medicalization: Discourses, Practices and Identities. He uses 
these dimensions as a way to structures his discussion of medicalization. Though this 
method has limitations, he states “the point is not to stuff processes and phenomena into 
boxes but to offer a sensitizing tool for identifying and analyzing medicalization.”115 
With this in mind, I will employ this tool in order to help analyze the medical frame’s 
influence on identity making.  
 Discourse includes “sign, symptom, syndrome, disorder, disease, illness, 
pathogenesis, pathology, contagion and ‘normal function,’” or other biomedical 
language, vocabulary or definitions as part of the discussion regarding the topic at 
hand.116 Halfmann states “medicalization increases when [these features] become more 
prevalent in discourses about social problems” and conversely decreases when such 
features of a discussion becomes uncommon.117 This level includes contributions from 
medical journals and universities, legislation or other government, corporation or non-
profit groups. These sectors are also contributing to the knowledge of the social problem 
simultaneously. The process and resulting knowledge of the problem has a strong 
influence on identity- making since the new problem provides a new way to categorize 
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people. Furthermore, “without medicalization in a definitional sense, medical social 
control loses its legitimacy and is more difficult to accomplish.”118   
 Practices, the second dimension, are the actions such as “ measurement, 
normalization, surveillance, risk assessment, medical insurance coverage, examination, 
lab tests,” etc. which may be considered appropriate responses to a problem.119 Action 
within this dimension is the result of negotiations among laboratory science, clinical 
science, and general acceptance that a problem falls within the medical context. This 
influences the medical interventions he may offer the patient. As a medical practice is 
normalized, its availability entices a patient to request it from his physician.  
 The last type of factor influencing the medicalization story is the actor that 
addresses the problem, which could be any combination of “physicians, biomedical 
researchers, hospitals, insurance companies, drug and device makers, medical schools 
and professional associations, ‘clients’, and practitioners like midwives who are 
considered “less biomedical.”120 The identity of these actors is meaningful as they 
assume responsibility for addressing the problem. This is especially important as social 
problems become medicalized because the “biomedical” identity of the medical doctor 
reinforces medicalization of a social problem more so than, say, a homeopathic 
physician. Furthermore, the patient may also construct a “biomedical” self- identity 
around their diagnosis; as the ability to become this type of person emerges, the category 
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also becomes a possible way to organize people. In this way, a group identity can arise 
based on a biomedical classification.  
 
IV. History and Discourses 
“Reality does not just exist out there in the world waiting to be discovered, but rather 
is created by individuals who act in and toward their world.”121 Thus, medicalization was 
not deployed and set on a pre-determined track to reach some end point. Rather, 
medicalization began based on the interaction of several social influences and took hold 
as those social influences created a tenable landscape for the phenomenon. 
According to Davis, the concept of medicalization was being discussed in the 
1950s in relation to mental health by psychiatrists as they began defining relevant social 
issues with moral underpinnings in medical language.122 Though medicalization of social 
issues was occurring as far back as the sixteenth century, the situation Davis alludes to is 
based on different factors.123 John Burnham summarizes several factors that helped 
resurrect the phenomenon in the 1950s. Among them, consumerism and the open 
marketplace seem to have created a hospitable environment in which pharmaceutical 
tranquilizers were advertised extensively and prescribed based on patient request, rather 
than physician or psychiatrist suggestion.124 Peter Conrad, Frank Furedi and Frederic W. 
Hafferty identify medicalization discussion occurring in the 1960s, 10 years later than 
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Davis and Burnham describe. Further research into this discrepancy may identify an 
additional wave of medicalization.  
This early application of biomedicine to moral problems is the basis for early 
rejection of medicalization as inappropriate application of medical knowledge to a 
problem beyond the professional biomedical scope. Davis cites Barbara Wootton’s 
distrust in the physician’s authority on moral issues and states “ ‘this victory of medicine 
over morals’ is improper in her view because the concepts of mental health and mental 
illness are not value- neutral, but disguise moral judgments. ”125 Neither this questionable 
basis for moral judgment, nor framing a social issue as a medical one have fallen by the 
wayside.  
 In “The End of Professional Dominance,” Furedi states that medicalization began 
based on the medical authority making achieved by professionalizing the medical field. 
This was largely achieved by implementing more rigorous training and higher standards 
for physicians, beginning with the Flexner Report. Published in 1910, the report surveyed 
the existing standards for medical education and signifies an important moment in 
medical history.126 As a result of Flexner’s proposed changes like closing inadequate 
medical schools and improving the curriculum, medical education became more 
reputable. The Flexner Report did not just make the curriculum more rigorous, but also 
called for it to be based more strongly in the hard sciences. Deferring to scientific data 
provided the M.D. with further legitimacy. As a result, a division arose between a 
                                                
125 Davis, Joseph E. 2006. “How Medicalization Lost Its Way,” 51-52.  
126 Flexner, Abraham. 1910. Medical Education in the United States and Canada: A 
Report to The Carnegie Foundation for the Advancement of Teaching, New York.  
  79 
‘qualified physician’ and another type of practitioner or healer, lending more credibility 
to the physician with a prestigious medical education. 
The scientific basis of medicine has been questioned by many, including theorists, 
ethicists and doctors themselves. Leonard Tushnet, a physician, calls the entire practice 
of medicine into question in his book The Medicine Men. His criticism of every feature of 
medicine from the language and vocabulary used, the instruments and methods applied 
and the treatments prescribed, leads him to the conclusion that, despite the increased 
‘scientific’ basis of medicine as a result of professionalizing the field, the mysticism of 
medical practice has not been removed. Rather, the lack of scientific understanding on 
the part of the physician and the patient has been replaced by a lack of understanding of 
the jargon and medical reasoning. A scientific basis of the medical profession makes the 
practice no more clear to the patient than that of the natural healer’s practice.  
The question of true legitimacy of medical authority is valid, but it is beyond the 
scope of this study to situate the rise of medicalization. Early research into this topic 
commonly ended at the idea that medicalization is a result of medical professionalization. 
However, the sociological and anthropological lens has provided a new perspective on a 
seemingly straightforward medicalization narrative which is typically characterized as a 
result of professional legitimacy and scientific medicine. Attention to the interaction of 
social and environmental influences on health enrich the story. Furthermore, Frederic 
Hafferty makes the case “that today’s physicians occupy a more subordinate role than 
previously and that medicalization of today is dominated more by commercial interests 
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and market (rather than professional claims-makers).”127 Thus, physicians and the 
medical profession are not the only driving force behind the medicalization phenomenon. 
It becomes a story of social negotiation of medicine’s role in identity- making. 
The social factors promoting or detracting from medicalization are lost when it is 
simply discussed in terms of the paternalism of the physician. The medical community’s 
role in identity-making becomes more interesting when considering that a functional 
aspect of the medical experience, such as diagnosis or routine treatments, carry 
implications for the patient outside of the clinic. Epidemiological studies showing risk 
associated with behaviors become justification for placing responsibility with the patient 
for any negative health effects after the behavior is committed. Diagnosis, especially of a 
stigmatized disease with moral connotations, becomes a commentary on the individual’s 
character. Routine treatments, such as chemotherapy, are based on practical, biological 
reasoning, and yet structure an individual’s life in an external fashion. The patient is 
compelled to adopt a new structure to his life such that the health component takes 
precedence over other life activities. If he does not yield to this routine, he runs further 
risk of deviance, in the form of being identified as a ‘non-compliant’ patient, and further 
decline in health leading to ever more certain death. The significance of separating the 
disease from the morally causative behavior cannot be fully answered by rejecting a 
subjective interpretation of disease and appealing to a scientific viewpoint. Though the 
literature does not support the simple statement that medicalization = destigmatization, it 
is important to remember that LCA’s picture of destigmatization is stated as such. The 
organization looks to several injustices that they say could be remedied by more medical 
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and biomedical research attention. Should inquiry stop here, it would shortchange a full 
consideration of LCA’s solution. 
 
V.  Deviance and Responsibility in the Medical Frame 
 The moral aspect of the stigma framework is more straightforward than the moral 
aspect of the medical framework. Each framework contributes to a moral aspect of 
disease that is underappreciated. As discussed in the previous chapter, norms and social 
reasoning processes allow a disease to be understood in terms of stigma. These features 
of the stigma framework are hidden in Lung Cancer Alliance’s campaign. LCA also 
collapses what it means for the individual to enter the medical framework and become a 
patient. The organization proposes society’s understanding of lung cancer be medicalized 
by suggesting that society should properly consider the individual with the disease as a 
patient. However, the medical framework maintains a relationship between disease, 
identity-making and responsibility. How is the perspective of the problem of (unjust and 
stigmatizing) public attitude toward lung cancer patients shifted by medicalizing the 
relationship between identity-making, disease, and responsibility? In other words, how 
does shifting toward the medical frame diminish the moral aspect of disease-related 
identity? As LCA’s solution for the negative public attitude about lung cancer patients, 
the implication is that the moral aspect of the stigma framework would be diminished. 
This solution provides insight into LCA’s picture of what destigmatization looks like.  
 The relationship between disease, identity, and responsibility is maintained in the 
medical frame. The authoritative source of knowledge in the medical frame is more 
obvious and discrete in this frame. Additionally, the norms tend to be stated more 
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explicitly. Physicians create expectations for the patient. The norm is that he follow those 
expectations with a fair amount of accuracy. For the individual to call himself ‘patient,’ 
he must comply with medical recommendations and follow through with all medical 
treatments. Illich states that the medical frame is not objective, as LCA implies, rather 
“medicine is a moral enterprise and inevitably gives content to good and evil. In every 
society, medicine, like law and religion, defines what is normal, proper, or desirable.”128 
Medicine provides for an empirical basis for identity- making via diagnosis. However, 
identity from a medical perspective is based on diagnosis only in part; a patient identity is 
also based on an underrepresented component of role fulfillment that is considered 
reflective of the patient’s character.  
  By ascribing diagnosis, the medical field adds a new feature to the individual’s 
identity. As with the stigma framework, the medical frame poses a tightly intertwined 
relationship between identity and responsibility. Unlike the stigma framework, the basis 
for comparisons lie within medical rather than social knowledge. In the medical frame, 
the individual is initially considered a patient upon the first visit to the physician, if for no 
other reason than by virtue of physically being in the clinic. He is initially considered a 
normal patient, where the normal patient category is independent from the disease 
category. By this I mean, all individuals in the medical frame are subject to normalizing 
expectations from the physician, regardless of the disease. The normal patient, who 
complies with recommended medical treatment, is a category that cuts across all disease 
categories. Normal behavior in the medical space is constituted by the patient taking an 
active role in managing his disease. Medicalization emphasizes the individual’s role as a 
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patient, which indicates that it is his responsibility to carry out reasonable medical 
recommendations that will stabilize or improve his condition. The ethical role is with the 
physician; however, medical care is ultimately the patient’s responsibility. Fulfillment of 
the patient role is the norm based on the medical establishment’s expectations. Ivan Illich 
characterizes the physician as ““a moral entrepreneur, charged with inquisitorial powers 
to discover certain wrongs to be righted. Medicine, like all crusades, creates a new group 
of outsiders each time it makes a new diagnosis stick. Morality is as implicit in sickness 
as it is in crime or in sin.”129 This is distinct from the normal (social) individual, whose 
normal behavior is determined based on values determining expected social interaction.  
In both cases, definition of the norm conversely defines deviance. Those that deviate 
from the norm simultaneously exist as a type of person that would not naturally accept 
certain (biomedical) treatments, and as a category exists of patients whose behavior does 
not fit with other patient’s “normal” behavior. Deviance from medical expectation in this 
way are judged to be “non-compliant” patients. Judgment of the patient’s willingness to 
accept medical advice signifies an individual of poor character in that he is not an 
individual who prioritizes his health. This “bad” patient is different from the other “good” 
patients who value their health and enact the medical advice for which they paid. Those 
individuals whose behavior places them in the normal category are awarded the name 
‘patient’ based on their merit. This kind of identity matches current behavior with the 
patient’s current character. Whereas identity in the stigma frame attempts to match past 
behavior with his current character. Therefore, lung cancer patients become responsible 
for managing their disease in order to manage and support their moral identity.  
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 In some ways, the medical frame is a more accurate representation of the 
individual’s current moral identity. It does not represent the individual’s overall identity 
though. The argument that was raised in arguments against stigma still applies here: the 
disease identity (and resulting patient identity) again takes over the individual’s full 
identity. The medical framework does not avoid categorizing the individual on the basis 
of a single attribute. In this case the attribute may be the patient’s ability to conform to 
medical recommendations, but it is still the same identity-making problem as experienced 
in the stigma framework. An unstated expectation is still held by the physicians, who 
hold the authoritative role within the medical frame. The expectation that the patient will 
make his disease as agreeable to the physician as possible, meaning he will ensure it is 
managed, and adhere to the medical code. Deviance from expectation and judgments 
regarding the patient’s behavior still occur. Responsibility is still held by the patient.  
 The lung cancer patient signifies an agreement from the medical community that 
“lung cancer patient” is a legitimate category in need of care and, an agreement in the 
research community that this disease and the harm it represents to society is worth 
investigation. Endorsement by the medical community helps build the case for increased 
federal research funding. Medicalization of a disease perhaps increases the possibility 
that the patient will be able to access proper clinical care and enjoy higher awareness of 
the disease. However, this at a personal cost to the patient, who must first demonstrate the 
legitimacy of his identity. In the medical frame, the patient is expected to take on the 
good patient role. This is based on the assumption the patient appropriately accepts and 
understands the diagnosis and is compliant with the treatment plan. What this assumption 
really means is that society's expectation of the patient is that he accept the 
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medicalization of part of his self-concept, his identity. Furthermore, it becomes his 
responsibility to do so.  
 Difference shapes the way an individual is categorized, as well as the very 
category in which he is placed. The medical frame can be viewed as a way to 
operationalize difference; it becomes a tool for exclusion or inclusion. Difference carries 
the same function in the stigma framework, but based on different reasoning. The degree 
of difference would not be eliminated; as one enters the medical framework: he is 
categorized according to disease. He would occupy a space of generalized responsible 
patients or cancer patients, rather than of the group of irresponsible people who risked his 
health to smoke and are now paying the price. Realistically, that valence may continue to 
exist. However, medicalization offers a new way to determine the category the individual 
fits into. The medical frame matches the difference that exists: a medical pathology and 
diagnosis. Furthermore, it is a widely accepted and pre-existing category. LCA is able to 
offer the medical frame as a legitimate replacement for the stigma frame because society 
has already undergone several waves of medicalization, each time allowing medicine into 
their lives and self-concept, or identity. The work has already been done to create medical 
categories and discover medical pathology. The existence of the category and the 
existence of the disease separate people into their corresponding boxes apparently based 
on a a diagnosis. However, moral identity is still applied to the individual based on his 
demonstrated commitment to prioritizing health(care). By becoming the responsible, 
compliant patient, he is able to take advantage of the health care treatments offered to 
him, assuming he has the means to do so.  
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 Lung Cancer Alliance’s push to shift away from the stigma framework toward the 
medical framework has a serious pitfall. Given the newest campaign that promotes 
prevention by utilizing the newly approved low-dose CT screening, the individual at risk 
for lung cancer or diagnosed patient becomes a consumer of medical technology. Making 
use of interventions such as low-dose CT ostensibly seems to be an expression of the 
patient’s rights to equal care and decrease the marginalized status of lung cancer via early 
detection. However, the patient must consume medical care in order to enjoy any benefits 
to his health status. He may not have the financial means, transportation, or time to do so. 
However, such externalities must be overcome to maintain “good patient” status and, 
therefore, a positive moral identity. This disproportionately favors some patients over 
others, and the overall lung cancer patient group remains marginalized. Though, 
medicalizing lung cancer may offer some benefit to the patient in the form of giving him 
more control over his identity, should he appropriately carry out the patient role, the 
troubled relationship between identity-making, responsibility and disease finds no relief 
in the medical frame.  
 The stigma and medical frameworks for disease are treated by Lung Cancer 
Alliance as shorthand for the types of relationships they signify. The traditional 
medicalization literature also collapses the significance of medicalization by deferring to 
arguments about medical authority and jurisdiction. While the theoretical literature does 
not support the simple equation medicalization = destigmatization, this equation is how 
LCA envisions destigmatization. The simple statement precludes further inquiry and 
defers to a statement about the correctness of LCA’s picture. Additionally, the very 
definition of medicalization encodes a critique of the phenomenon by characterizing it as 
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an inappropriate application of medicine to a social problems. Yet, for the discussion at 
hand, it is important to set aside judgment about the phenomenon in order to give 
adequate attention to the picture of destigmatization LCA holds. If we begin from a 
neutral stance about applying the medical framework, and from a place where medical 
authority is given, the detailed relationships the medical frame encodes can be examined. 
The relationship between disease, identity-making and responsibility is applicable to the 
medical frame, but through a more complicated interaction than found in the stigma 
frame. LCA implies these relationships and refers to them in the campaign in a way that 
the audience immediately understands. In this way the relationships and contributing 
features, such as comparison, difference assessment, and normative judgment, are 
collapsed. Because the audience understands, LCA is able to used stigma and medicine as 
a framing device without theorizing the concepts. Upon exploration, the shift toward the 
medical frame connects relationships between disease, identity-making, and 
responsibility in a different way than they were connected in the stigma framework. In 
the medical framework, the individual is given the patient label before a comparison and 
assessment of difference occur. The patient must demonstrate that he is taking active 
responsibility for his disease in the manner prescribed by the physician. If the individual 
follows the expectations, no difference is found between his actions and the norm. 
Therefore, he is allowed to continue as a ‘normal patient.’ If he does not fulfill his patient 
role as expected, he deviates from expectation. By no longer fitting with the norm, 
compliance with medical recommendation, the patient is considered non-compliant and 
considered a ‘bad patient.’ In other words, the patient must work to maintain his identity. 
  88 
He must demonstrate responsibility in order to sustain the current ‘good patient’ identity. 
Reflection of this sort on the individual’s identity maintains the moral aspect of disease. 
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CHAPTER 6 
CONCLUSION 
 Difference can be assessed from multiple perspectives. Perceived difference has a 
strong impact on identity- making. Within the stigma framework, difference is assessed 
based on comparison between the observed and the expected. Expected behavior is based 
on an embedded norm that often goes unacknowledged.130 The invisible cultural norm 
leads to a moral explanation for the resulting disparity. In this way understanding of 
identity adopts a positive or negative quality. These are major features of identity-making 
that are made visible when framing a disease in terms of stigma.   
 The definition of stigma has morphed over the past 50 years to emphasize the 
negative connotations of the concept that take precedence in the common-sense 
understanding of stigma. This way of understanding disease with a set of assumptions 
and responded to with a set of generally accepted practices, or this framework, is 
therefore infused with this negativity. Whether or not this diminishes the integrity of the 
definition, it is indicative of how the concept is commonly applied. Disease is a common 
area where this kind of identity-making is applied. Several authors cited in this thesis, 
including Goffman and Sontag, make the case that disease is historically believed to 
reveal the underlying character of the diseased. Thus, these actions can simultaneously be 
considered as identity-making for the individual, and disease-identity-making for the 
group. Lung cancer provides an ideal space to examine the relationship between disease 
and identity. The individual with lung cancer assumes a lower status than other types of 
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individuals with cancer due to the perception that he knowingly risked his own health. 
The common sense knowledge says “he did it to himself.” Therefore, unlike others with 
cancer, he does not deserve sympathy when it comes time to bear the consequences of his 
misbehavior. This reasoning is extrapolated to the group level when this kind of disease 
identity is used as a method to determine the claims individuals can make on society.  
 LCA’s campaign asserts that public attitude about lung cancer is stigmatizing. 
Lung cancer should not be stigmatized, according to LCA. The non-profit organization’s 
argument is that the disease is inappropriately understood within the stigma framework. 
Within this frame, lung cancer patients are primarily understood as moral actors. Because 
of this, individuals with lung cancer are denied opportunities that have shown to greatly 
benefit other cancer patients. Therefore, individuals with lung cancer should be 
understood as patients only. By shifting this understanding of the diseased, society will 
be fulfilling its responsibility to allow the patient a structure within which to make claims 
on society. Lung Cancer Alliance, the only organization of its type to target the stigma 
framework, implies that understanding of the disease should be medicalized. Identity-
making and responsibility are features of stigma that are operationalized in the text and 
visuals included in the “No One Deserves to Die” campaign released by Lung Cancer 
Alliance in June 2012. The case highlights that membership to a devalued disease group 
not only impacts the individual on a personal level, but also impacts how society 
approaches the disease. In this way, social responsibility has a direct impact on the 
tangible markers of injustice against individuals with lung cancer. By striving to change 
public attitudes about lung cancer, LCA aims for a morally neutral frame for this disease. 
 This theoretical research provides a review of the social interactions that serve as 
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a basis for creating the cultural understanding disease. Both the medical and stigma 
frameworks influence the relationships between disease, identity, and responsibility. It is 
significant that Lung Cancer Alliance tells the audience that the injustices felt by lung 
cancer patients is “stigma.” The framework of stigma is considered a moral 
understanding of disease by LCA. However, as LCA implies, this is a moral 
understanding that has gone unexamined. The organization tells the narrative of lung 
cancer and negative social attitudes as a flat map of linear thinking: stigma= unjust 
attitude = exclusion. Society has a common sense understanding of lung cancer that 
glosses over the actual social interactions that generate the relationship between disease, 
identity, and responsibility. Complex social interactions come to light by asking how this 
relationship is made, given that Lung Cancer Alliance’s stigma narrative compresses the 
complexity of the story. By calling the phenomenon ‘stigma,’ LCA is able to package a 
whole process of social interaction into one term that is assumed to be understood by the 
audience. When breaking this package into its pieces, we see that identity is attributed to 
the individual with lung cancer when society compares him with other types of cancer 
patients. When difference is seen between these types of patients, the difference is 
explained by society with the insertion of a normative judgment. The difference 
attributed is often based on unstated norms, according to Martha Minow. The normative 
judgment alters the individual’s identity. This process of identity-making leads to 
corollary responsibilities for society and for the individual. The stigmatized individual is 
expected to take responsibility for his past actions, according to Goffman. Yet, LCA 
states larger society is responsible for stigmatizing individuals with lung cancer. It is 
society’s social attitudes based in moral judgments of lung cancer that are responsible for 
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preventing progress in lung cancer research and improvements to mortality rates. The 
stigmatized are told that the social responses they encounter when managing their disease 
are unacceptable. The stigma attached to their disease is no fault of their own; rather, it is 
due to an unexamined social attitude. This attitude causes the proxy effects of stigma in 
the form of underrepresentation in federal research funding, minimal intervention to 
improve 5-year- survival rates, and low awareness of the disease.  
 Lung Cancer Alliance offers medicalization of public attitude toward lung cancer 
as a solution for the injustices felt by lung cancer patients in terms of federal research 
funding, clinical care, and awareness. In the medical framework, identity is earned by 
successfully assuming the patient role. Where identity in the stigma framework 
retroactively interacts with responsibility by assuming that the individual is responsible 
for causing the disease, identity from the medical perspective is determined by active 
responsibility for managing the disease. Fulfillment of the patient role is the established  
norm based on the medical community’s expectations. Responsibility for the disease is 
shifted back to the patient. This, perhaps unexpectedly, has a moral implication. Though 
it de-emphasizes a patient’s past transgressions against his health, the medical framework 
only allows a patient a positive identity when he properly carries out the patient role. 
However, the medical frame provides a method for the individual to take active 
responsibility for his disease. By fulfilling the patient role, the individual can legitimately 
claim his rights to representation. Therefore, medicalizing the relationship between 
identity-making, disease, and responsibility does not remove moral implications about the 
individual’s character. Nor does understanding the disease in the medical framework 
absolve the patient of personal responsibility of his disease. Rather, it offers a different 
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organization and interaction of the relationship between disease, identity, and 
responsibility. 
 This research effort has opened more questions than it has answered, as most do. 
In-depth inquiry into the genealogy of the concept/framework of stigma would provide a 
more complete picture of the way this particular frame for understanding disease has 
evolved. In addition, further research into what kind of disease frame would reduce 
harms felt by patients would have a broad impact. Many other types of disease whose 
cause is blamed on the diseased, such as mental illness, HIV/AIDS, obesity, alcoholism, 
and disability, experience some level of stigma with tangible harms unique to each 
situation. This research shows that the relationship between the disease, identity-making 
activities and responsibility is not altered significantly by shifting the framing of the 
disease from stigma toward medicine. Though this research does not aim to analyze the 
effectiveness of the campaign or its recommendations, it may be that Lung Cancer 
Alliance’s solution to the problem of injustice may not be the most prudent. Finally, the 
question of how the disease character, especially its mortality- rate ranking, alters 
understanding of the disease identity is especially interesting. One may ask if, and how, 
the stigma frame changes in relation to the social implications of the disease. This 
question could be broadened to ask, how a different social context changes common 
understanding of and assumptions about a particular disease. Lung cancer is not just an 
American problem. Allen Brandt describes the growing problem of smoking and lung 
cancer as exported to developing countries by American companies disfavored 
domestically. This inquiry has unpacked the step-wise behaviors that build the stigma 
framework; awareness of the features of these frames that produce harms for the 
  94 
individuals/patients provides “another terrain for reconsidering the relationships and 
patterns of power that influence the negative consequences of difference.”131 Future 
attempts to alter these relationships could build on this knowledge to bring about a true 
shift away from understanding disease in stigmatizing terms. Even simple awareness of 
how a stigma framework causes harms may benefit future lung cancer patients in this and 
other countries. Such awareness may provide them with equitable treatment before the 
American framework of stigma is exported and causes deadly marginalization. Such 
inquiries would be able to build off and contrast against knowledge provided here about 
the identity of lung cancer, the second largest killer in America.  
   
                                                
131 Ibid., 78 
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APPENDIX A  
“NO ONE DESERVES TO DIE”PHASE I CAMPAIGN POSTERS 
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“No One Deserves To Die” Campaign posters were displayed on bus bench shelters, 
buildings, payphones, print media, and on the internet. They were released exactly as 
shown below with no explanation of the meaning behind the statement or the campaign 
for one week in June 2012.  
 
Lung Cancer Alliance June 2012132 
 
 
 
 
 
                                                
132 All images found in Appendix A and B can be found on the advertising agency, 
Laughlin Constable, website. Laughlin Constable. 2012. “Lung Cancer Alliance: No One 
Deserves to Die” http://www.laughlin.com/clients/lung-cancer-alliance/campaigns/no-
one-deserves-to-die/work/hipsters-deserve-to-die 
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APPENDIX B  
“NO ONE DESERVES TO DIE”PHASE II CAMPAIGN IMAGES 
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Images released after the initial week of the campaign. At that time, the campaign and its 
meaning were explained to the public audience.  
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Hipsters Deserve To Die – 
the extended version with an explanation of the campaign and the problem it is meant to 
address. 
The text reads: 
 HIPSTERS DESERVE TO DIE if they have lung cancer. Many people believe 
that if you have lung cancer you did something to deserve it. It sounds absurd, but it’s 
true. Lung cancer doesn’t discriminate and neither should you. Help put an end to the 
stigma and the disease at NoOneDeservesToDie.org.  
    Lung Cancer Alliance 
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APPENDIX C  
INTERVIEW WITH GABRIELE GEIER, COMMUNICATIONS MANAGER AT 
LUNG CANCER ALLIANCE 
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Prepared Questions 
 
1. How did you measure success of the campaign? 
a. Increased public discourse about lung cancer? 
b. Impact on legislative action? 
c. Influx of research funding? 
 
2. What is Lung Cancer Alliance’s definition of stigma? 
 
3. Was the campaign release targeted to certain areas? 
a. How did you choose those areas? 
b. Is Lung Cancer Alliance’s new campaign promoting risk awareness 
focused toward the same audience? 
 
4. Will reducing injustice and stigma associated with the disease break the link 
between lung cancer and smoking? 
 
5. Has Lung Cancer Alliance thought about the negative effects of reducing stigma, 
i.e. opening the door to increased incidence of smoking? 
 
6. What is next for Lung Cancer Alliance?  
